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Abstract 
This thesis describes research into the roles that metalloproteins and 
non-metalloproteins play in the biological inorganic/organic chemistry of 
common nitrogen oxides. There are three main chapters on this work: the first 
details the reactions of wild-type and mutant myoglobins (Mbs) in their 
interactions with nitrite and nitric oxide (NO), the second deals with these Mbs 
and their formation of bioorganometallic derivatives when reacted with 
arylhydrazines, and the third deals with an FMN-dependent nitroreductase 
enzyme and its reactions with the clinically relevant metronidazole drug. 
Mutations to the distal pocket in the active site of Mb were made; 
specifically, the ferric-aqua derivatives of the H64A, H64Q, and V68A/I107Y 
mutants were expressed, purified, crystallized, and their crystal structures 
solved to 1.78-1.85 Å resolution. The proteins crystallized in either the P21 (wt, 
H64Q, V68A/I107Y) or P6 (H64A, H64Q) space groups. The crystals were 
soaked with nitrite to form their O-bonded MbIII(ONO) complexes whose 
structures were also solved to 1.57-1.85 Å resolution. In the case of the H64A 
distal pocket mutant missing the H-bonding amino-acid residue in the 64th 
position, a water bridge was observed to form linking the protein exterior with 
the bound nitrite ligand, thus replacing the expected wt H64 H-bonding feature. 
Further, we noted that the distal pocket Val68 residue adapted its conformation 
to accommodate the nitrite ligands in some of these complexes. Notably, the O-
binding modes observed in the four structures wt Mb(ONO), H64A-Mb(ONO), 
H64Q-Mb(ONO), and V68A/I107Y-Mb(ONO) held up exceedingly well even 
xvii 
with the variation in H-bonding capacities. These wt and mutant Mb(ONO) 
compounds can be reduced with sodium dithionite to their respective nitrosyl 
Mb(NO) products. Surprisingly, although the precursor nitrite Mb(ONO) 
compounds had similar Fe-ONO orientations in the protein active site pockets, 
two different orientations of the Fe-NO moieties in the products were observed; 
one had the NO ligand tilted and pointing towards the hydrophobic protein 
interior (for wt and V68A/I107Y), whereas the other had it pointing towards the 
hydrophilic protein exterior (for H64A and H64Q). Verification of the formation of 
the nitrosyl Fe-NO derivative, and not the closely related nitroxyl Fe-HNO, was 
provided by FT-infrared spectroscopy. 
Arylhydrazines and derivatives are prevalent in nature and in 
pharmaceutical drugs. They interact with various heme proteins resulting in 
deactivation of the proteins. Eleven X-ray crystal structures of the products from 
the reactions of wt and mutant (H64A, H64Q, V68A/I107Y) Mbs with 
arylhydrazines (ArNHNH2; Ar = Ph, m-tol, and p-chlorophenyl) were obtained to 
1.70-1.98 Å resolution. Direct Fe-carbon bonds were observed in all these 
derivatives, establishing that the hydrazine -NHNH2 moieties had been 
released from the reagents during their reactions with the Fe centers of the 
Mbs. Importantly, the C-atoms coordinating to the Fe centers were the same as 
those that bonded to the hydrazine functional groups, implying that the carbon-
based radical intermediates were formed in close proximity to the Fe centers 
allowing for facile and efficient reactions to give the bioorganometallic Mb-aryl 
products. Significant distal pocket amino acid movements were observed in 
xviii 
some cases with the larger p-chlorophenyl ligand aryl; for example, in the 
H64Q-chlorophenyl derivative, the Gln64 residue swings to a position outside 
the pocket towards the solvent region. 
We report the first expression, purification, crystallization, and X-ray 
crystal structure of a nitroreductase (NR) protein from the hypervirulent 
Clostridium difficile R20291 strain. This NR protein was isolated in dimeric form, 
and possesses the classical NR fold, with one FMN cofactor per monomer. The 
crystal structure was solved to 2.1 Å resolution, and shows a phosphate anion 
in one of the active sites. Evidence of functional nitroreductase capacity was 
demonstrated by the ability of the reduced NR protein to reduce a commonly 
prescribed drug for C. difficile infections, namely metronidazole. 
 
1 
Chapter 1 Introduction 
 
In Dr. Richter-Addo’s lab, we are mainly interested in the structures and 
reactivities of heme active sites in hemeprotein derivatives (hemeprotein + 
ligand). We examine the interactions of hemeproteins with endogenous and 
exogenous small molecules. We are also interested in the mode of attachments 
of these ligands to heme iron, and the effect of distal amino acid residues on 
ligand binding and reactivity. 
Hemeproteins containing heme prosthetic groups are a group of 
metalloproteins that broadly exist in nature and are also intensively explored 
due to their diverse biological functions ranging from oxygen binding and 
transport (e.g., hemoglobin (Hb) and myoglobin (Mb)), electron transfer (e.g., 
cytochrome c), catalysis (e.g., cytochrome P450), to signaling (e.g., soluble 
guanylyl cyclase (sGC)) [1]. We currently focus on Hb and Mb. Hb and Mb are 
probably the most investigated heme-containing macromolecules. They occur 
widely in our body and are now believed to perform multiple roles. New 
functions of these two proteins, other than their known function as the oxygen 
carriers and storage units, have been assessed and some of these possible 
new functions are being studied.  More attention has been drawn to these two 
proteins due to their new likely roles as nitrite reductases. Hb and Mb can 
reduce nitrite (NO2
-) to nitric oxide (NO) which vasodilates blood vessels as a 
compensatory pathway for NO biosynthesis by nitric oxide synthase (NOS) 
during the hypoxia [2-4]. 
2 
Sperm whale myoglobin (sw Mb) is used in this work. In Chapter 2, the 
interaction of Mb with nitrite and nitric oxide ligands is explored. Mb is a 
monomeric protein of ~18 kD. Mb can reduce nitrite to NO in the cardiomyocyte 
and in the rat heart [5, 6]. NO derived from Mb inhibits cellular respiration 
through binding to cytochrome c oxidase, limiting electron flow and oxygen 
utilization. In addition, knockout Mb-/- mice do not display the conversion of 
nitrite to NO, and exhibit a loss of nitrite protection against myocardial infarction 
[6]. Based on these results, Mb is suggested to behave as an intrinsic nitrite 
reductase that regulates cardiac function [7]. X-ray crystallography allows us to 
examine the interactions of Mb with nitrogen oxide ligands. Different mutants 
around the heme distal pocket were prepared in this work to investigate the 
effect of these residues on ligand binding modes and orientations. The liganded 
complexes of the wild-type and mutant Mbs were characterized by UV-vis, 
protein IR spectroscopy, and X-ray crystallography. 
Humans encounter an increasing number of exogenous compounds, 
including environmental contaminants from industrial factories and 
pharmaceutical companies. Hemeproteins can be inhibited by metabolites of 
these compounds through the formation of organometallic iron-carbon (Fe-C) 
bonds. For example, cytochrome P450 can interact with phenylhydrazine, an 
intermediate in the synthesis of various dyes and pharmaceuticals in industry, 
to form Fe-phenyl complexes resulting in the inhibition of P450 activity [8-10]. A 
similar result was also observed in Mb [11-13]. The sw Mb protein is used in 
Chapter 3 to investigate its interaction with arylhydrazines. X-ray 
3 
crystallography and UV-vis spectroscopy are the main characterization tools 
used in this work. 
Clostridium is a Gram-positive bacterium, which includes several 
significant human pathogens, such as Clostridium botulinum and Clostridium 
difficile [14]. One of our projects, funded by the Price Family Foundation, 
focuses on finding druggable targets in the hypervirulent Clostridium difficile 
strain R20291. While searching for iron-sulfur metalloproteins from R20291 
(these iron-sulfur proteins are important in energy metabolism [15]), we also 
found some other interesting targets, e.g. nitroreductases, which are FMN-
containing proteins. In bacteria, nitroreductases are non-metal enzymes that 
catalyze the reduction of nitro-containing compounds to produce toxic 
hydroxylamines. One of the commonly used antibiotics is the nitro compound, 
metronidazole. Nitroreductases are implicated with metronidazole resistance C. 
difficle. We are interested in the interaction of nitroreductases and 
metronidazole, and have employed X-ray crystallography and UV-vis 
spectroscopy to examine this protein and the interaction with metronidazole. 
This work is described in Chapter 4. 
 
 
 
 
 
4 
1.1 Metal containing hemeproteins interact with nitrogen oxides  
The research history of the inorganic nitrite salt seems like riding on a 
roller coaster. It is filled with controversies. Writing this Ph.D. thesis provided 
me with a good opportunity to examine this area.  
Nitrate and nitrite were used to preserve food >5000 years ago [16]. An 
ancient written document originating in 8th century China described people 
using nitrate/nitrite to treat cardiovascular disorders [7]. In the 19th century, 
nitrite rather than nitrate was used in curing and preserving meats in industry, 
after it was realized that nitrate is reduced to nitrite by bacteria (see equation 1-
1)  [17]. Nitrite serves three functions in the preservation of meats. Nitrite 
contributes to the fresh-like pink color of cured meat caused by the formation of 
Mb-NO from the reaction of nitrite and Mb, enhances flavor due to the inhibition 
of rancid smell, and enables a longer shelf life because of the growth inhibition 
of Clostridium botulinum [15, 17, 18]. 
 
The health concern of nitrate/nitrite, from both academic and public 
realms, began drawing more attention in the 1950s because carcinogenic N-
nitrosamines [19] from nitrate/nitrite were identified from heated or cooked 
nitrite treated meats [20-22]. On the other hand, it was doubted that 
nitrate/nitrite was the direct link to cancer because treated meats also contain 
many other “harmful” components such as saturated fat [23]. Although the 
controversy still exists, these data helped enable the strict control of the 
nitrate/nitrite levels in food and drinking water. Nitroso compounds can also 
5 
form from the reactions of nitrite with various peptides or amino compounds in 
the acidic environment of the stomach [15]. Much more attention in the scientific 
community has been put into the possible link of ingested nitrite and gastric 
cancer [24-27]. However there is no conclusive evidence to date that directly 
links the carcinogenicity to nitrate/nitrite [25, 28].  
The endogenous nitrite in mammals can derive from the oxidation of 
nitric oxide (NO), which is an important signaling gas molecule and serves 
many physiological functions, including host defense in the immune system, 
regulation of blood flow as a vasodilator, platelet activity and aggregation, and 
leukocyte trafficking [29-37]. NO is biosynthesized from L-arginine oxidation by 
nitric oxide synthases (NOS) in the presence of oxygen (see the scheme below) 
[38]. The reduced NO bioactivity in vasculature has been associated with 
cardiovascular diseases induced by inflammation, aging, hypertension, 
hypercholesterolemia, smoking, diabetes, postmenopause, and physical 
inactivity [32-37]. 
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It is interesting to point out that once NO is formed from NOS, it will be 
quickly converted to nitrate by oxymyoglobin (MbIIO2) or nitrite by the 
ceruloplasmin in plasma [39]. Are these nitrite molecules a threat to our health? 
The answer is obviously “NO”. Despite public anxiety regarding nitrite exposure, 
some seminal work has been reported in the recent 20 year period that 
suggests nitrite to be a vital nitrite oxide reservoir no matter where the nitrite 
comes from [7, 18, 40, 41]. When nitrate/nitrite containing food is consumed, 
part of this nitrate will be reduced to nitrite by the nitrate reductases from the 
bacteria in the oral cavity [42]. Mammals lack the enzymatic capacity to reduce 
nitrate to nitrite. The commensal bacteria provide a reciprocal metabolic 
pathway. The stomach can consume some of the nitrite by protonating the 
nitrite to form nitrous acid (HNO2) [29, 30]. The remaining nitrate and nitrite will 
be absorbed by the intestine and enter into circulation [7]. The nitrite in blood 
can be reduced to NO by deoxyhemoglobin (HbFeII) (see equation 1-2 below) 
under hypoxic conditions, and nitrite can work as a stable storage of NO [2-4, 
43]. NO diffuses into the smooth muscle and dilates the vessels causing 
increased local blood flow to meet O2 needs during ischemia or hypoxia [4]. 
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Nitrite induced vasodilation is an important regulatory mechanism during 
hypoxia since endogenous NOS-synthesized NO with O2 present will be limited.  
 
Deoxymyoglobin (MbFeII), like Hb, can also reduce nitrite to NO like Hb 
[5, 6]. This implies that Mb may play similar roles as Hb in nitrite induced 
vasodilation. It was recently shown that Mb is expressed in the vasculature and 
contributes to nitrite induced vasodilation [44]. Mb also displays specific 
functions in vasodilation because it is mainly expressed in cardiomyocytes and 
muscle cells [45]. NO, from nitrite reduction by Mb, can interact with cytochrome 
c oxidase in the mitochondrial electron transport chain and further limit cellular 
respiration and oxygen usage [5]. We thus need a better understanding of the 
conversion of nitrite to NO. Possible treatments using nitrate/nitrite for 
hypertension [46, 47], tissue protection in ischemia-reperfusion (IR) injury [48-
50], myocardial infraction [7], antimicrobial effects [51],  and gastric ulcers [52] 
are currently being pursued by others .  
It has been contended that nitrate/nitrite should be recognized as 
bioactive and indispensable nutrients, specifically for patients with a 
dysfunctional L-arginine-NOS pathway [53]. The supplementation of 
nitrate/nitrite in the diet has also been suggested for the treatment and 
prevention of cardiovascular disease [41]. However, it is undoubtable that nitrite 
is toxic to humans in high concentrations. The oxidation of oxyhemoglobin 
(HbFeIIO2) by nitrite can produce methemoglobin with loss of oxygen binding 
capacity, and cause the acute methemoglobinemia. This can be fatal, especially 
8 
for infants. The “blue baby syndrome” caused by methemoglobinemia has been 
associated with high nitrate/nitrite intake [54]. Thus, toxicity and benefit coexists 
in nitrate/nitrite, just like with most other chemical drugs.  
This background explains why our lab focuses on the reactions between 
Hb/Mb and NOx, currently between Hb/Mb and nitrite/NO. We are interested in 
the binding modes of nitrite in Hb/Mb, the relative effects of heme distal pocket 
on the nitrite ligands, and NO orientation preferences in Hb/Mb. Mb is my target 
in this work as shown in Chapter 2. The Mb protein fold is shown in Fig. 1-1. 
 
 
Fig. 1-1. Mb with each helix and heme site labled (PDB ID 2MBW [55]). The circled 
area shows the heme site. In the heme site, the area above heme containing His64 is 
called the “distal pocket”, and the area underneath the heme containing a proximal 
His93 is called the “proximal pocket”. 
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1.2 Metal containing hemeproteins react with arylhydrazines  
Applied organometallic chemistry has been associated with the catalysis 
industry and diverse areas in biology and medicine, such as anticancer therapy 
[56], antibacterial [57], radioimaging [58], and fluorescent cell imaging [59]. The 
first association of organometallics with biology was with vitamin B12 or 
cobalamin which works in a variety of life processes using a metal-carbon bond 
[60]. Heme containing proteins can also involve organometallic chemistry when 
they react with arylhydrazines [61, 62].  
As I detail in Chapter 3, arylhydrazines (ArNHNH2; Ar = aryl) occur in 
nature and are important chemical species in both the agrochemical and 
pharmaceutical industries [63], and synthetic hydrazines are also prevalent in 
the general environment [64].  
Phenylhydrazine is toxic to red blood cells [65], and the hemoglobin-
phenylhydrazine interaction has been used to examine and model hemolytic 
anemia. Interactions of various substituted hydrazines with Mb [11-13], 
cytochrome P450 [8-10], and catalase [66] have been reported in the literature 
[67]. Direct organometallic bond Fe–C(aryl) linkages may form from these 
reactions. 
 New X-ray structural data that clarify which aryl C atoms bind to the Fe 
centers, and information regarding preferred aryl ligand orientations from 
reactions involving substituted arylhydrazines as a function of active site 
structure are thus desirable. My research in this area is described in Chapter 3. 
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1.3 Non-metal nitroreductases metabolize organic nitro compounds 
Clostridium difficile infections (CDIs) cause ~14,000 deaths yearly out of 
the total ~250,000 cases reported by the CDC in 2013 [68]. Only two years 
later, these numbers doubled to ~29,000 deaths out of the total ~500,000 cases 
[69]. CDC labeled this pathogen as “Urgent” which is the top threat level [68]. 
CDIs result in at least $1 billion in excess medical costs every year [68]. C. 
difficile multiplies in the colon and causes life-threatening diarrhea [70]. The 
incidence and mortality rate are continuously increasing. One of the reasons is 
the frequent usage of antibiotics and chemotherapeutics which creates an 
imbalance in the intestinal flora and allow the rapid expansion of C. difficile [71]. 
Currently, metronidazole (MTZ) is a commonly prescribed drug for the 
treatment of CDI [72-74]. However, MTZ resistance has been reported recently 
[75, 76]. The search for the multiple therapeutic approaches is urgent, including 
the exploration of new therapeutic methods, the development of new drugs and 
the discovery of new druggable targets. 
As a collaborative project, we contribute to the search for new 
therapeutic approaches to CDIs. Nitrite is applied in meat preservation due to 
its inhibition against the growth of pathogens, in particular Clostridium botulinum 
[15]. This antibacterial role of nitrite is actually due to NO formation [77]. NO is 
toxic to Clostridium by inactivating the iron-sulfur proteins which are important in 
bacterial energy metabolism [78]. Accordingly, C. difficile does display only a 
low concentration of nitrite reductase capacity [79], avoiding the generation of 
toxic NO.  Sobko et al. [80] measured the NO gas generation from fecal and gut 
11 
bacteria. The data showed that C. difficile did not produce significant amounts 
of NO in the presence of either nitrate or nitrite. It was also reported that 
reduced gastric acidification from pH 2 to 5 caused the abolishment of nitrite 
reduction to NO and increased the risk of CDIs in patients [81]. These data 
suggest NO can be an efficient anti-CDI reagent. In fact, the antibacterial 
activity of NO against Helicobacter pylori has been assessed [52]. Both H. pylori 
and C. difficile colonize the lower gastrointestinal tract. The bactericidal effect of 
NO to H. pylori allows for hypothesis that NO could be used as the possible 
treatment for CDI. Our group focuses on the reaction mechanism of NO and 
iron-sulfur proteins (data not included in this thesis). We believe the knowledge 
of NO inhibition of Clostridium can result in future pharmaceutical applications. 
While we were working on selected iron-sulfur proteins from C. difficile, 
another group of enzymes, namely nitroreductases, also attracted our attention. 
Nitroreductases in pathogens reduce nitro compounds to toxic hydroxylamines 
[82]. Many nitro-containing prodrugs are designed based on this 
characterization of nitroreductases. MTZ is also a nitro drug. The emergence of 
MTZ resistance is linked to the nitroreductases in Helicobacter pylori [83] and 
Bacteroides fragilis [84]. A frame-shift mutation in one of the nitroreductases in 
the hypervirulent C. difficile strain R20291 is associated with MTZ resistance 
[85]. Understanding nitroreductase interaction with MTZ is urgently needed to 
combat MTZ resistance in C. difficile. The crystal structure of an nitroreductase 
and its activity with MTZ is described in Chapter 4.  
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Chapter 2 Interactions of sperm whale myoglobin with nitrite 
and nitric oxide ligands 
 
2.1 Introduction 
Nitrite reduction to nitric oxide (NO) is an important component of the 
global N-cycle, where nitrite reductase (NiR) enzymes are the key 
metalloenzyme species involved (equation 2-1). 
 
Although the mammalian heme proteins hemoglobin (Hb) and myoglobin 
(Mb) are known to stoichiometrically reduce nitrite to NO, it was only during the 
last decade or so that these Hb [1-4] and Mb-induced [5-7] processes were 
proposed to be physiologically relevant. Interestingly, prior to our work in this 
area, all published heme-NO2 complexes contained N-bound nitrite ligands (Fig. 
2-1) [8-11]. 
The heme pockets of the heme-nitrite adducts in Fig. 2-1 are quite 
diverse. Cytochrome cd1 NiR (top left) has a heme pocket that supplies two H-
bonds to one O-atom of the coordinated nitrite. Sulfite reductase (top right) has 
a heme pocket that stabilize both nitrite O-atoms using three H-bonds; here, the 
heme also contains a proximal cysteine. Cytochrome c NiR (bottom left) and 
cytochrome c NiR Y218F (bottom right) stabilize bound nitrite using two H-
bonds; here, the heme is coordinated by a proximal lysine.  
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Fig. 2-1. Heme sites of the nitrite complexes of cytochrome cd1 NiR from P. 
pantotrophus (top left; PDB ID 1AOM), sulfite reductase from E. coli (top right; PDB ID 
3GEO), cytochrome c NiR (bottom left; 2E80) and its Y218F mutant (bottom right; PDB 
ID 3BNH) from W. succinogenes. 
 
Based on the published work, we thought that Mb and Hb would also 
coordinate nitrite via the N-binding mode. Our lab determined the crystal 
structures of the nitrite adducts of Hb [12] and Mb [13], and showed, 
surprisingly, that the nitrite coordinated via the O-binding mode (Fig. 2-2). 
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Fig. 2-2. Fo-Fc omit electron density maps (contoured at 3σ) and final models of the 
heme sites of ferric horse heart Mb (A; PDB ID 2FRF) and human Hb (α subunit in B, β 
subunit in C; PDB ID 3D7O). 
 
Theoretical calculations on the model (P)Fe(NO)(NO2) compound 
showed that the nitrito (O-bound) FeONO isomer was only ∼4.3 kcal/mol higher 
in energy than the nitro (N-bound) FeNO2 isomer [14]. Why then does the nitrite 
bind with heme iron in Hb and Mb with this unique O-binding mode? This 
question raised our interest in determining what factors influence the NOx 
ligand binding mode in these heme proteins. It is expected that the reactivity of 
a ligand is a direct consequence of its binding mode. Therefore, understanding 
the binding modes of nitrite in Hb/Mb-NO2 is important to explain the inherent 
chemical properties of these NOx species.  
We proposed earlier that three components in the heme pocket could 
impose restrictions on the ligand binding mode: (i) the type of metal in the 
heme, (ii) the distal residues around the ligand, and (iii) the type of macrocycle. 
In our Mb and Hb systems, nitrite binds to the ferric centers in their proteins. 
Thus, the O-bound nitrite in ferric Hb/Mb (d5) may not be in the same 
A
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conformation in the reduced ferrous Hb/Mb (d6) systems. We reported the X-ray 
structures of the related MnIII (d4) and CoIII (d6) substituted derivatives (Fig. 2-3A 
and B) [15]. The O-binding modes were exclusively adopted by the nitrite 
ligands even with these different metal substituted derivatives. In addition, 
utilizing synchrotron X-ray radiation at high photon flux (3 X 1010 protons/s, λ = 
1.0 Å, total X-ray dose of ~0.42 MGy), to photoreduce the ferric center to 
ferrous, still showed the O-binding mode of nitrite in the reduced MbIIONO (d6) 
derivative (Fig. 2-3C) [16]. 
 
 
 
Fig. 2-3. Fo-Fc omit electron density maps and final models of the heme sites of Mn
III-
substituted Mb (A; contoured at 3σ; PDB ID 2O5O), CoIII-substituted Mb (B; contoured 
at 3σ; PDB ID 2O5S), and ferrous MbII(ONO) product  obtained after exposure of the 
ferric precursor to high intensity X-ray radiation (C; contoured at 5σ; PDB ID 3LR9).  
 
As noted above, the distal residues may, in principle, also affect the 
binding mode of nitrite ligands. Most likely, His64 plays an important role in the 
ligand O-binding mode since there is a H-bond between the Nε(H64) atom and 
the O1(NO2) atom. A mutant H64V-nitrite derivative was prepared and its 
structure solved (Fig. 2-4A) [14]. It was exciting to see that the nitrite sits in the 
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pocket with the (now) N-binding mode but with a very weak Fe-NO2 interaction 
(~2.6 Å). A double mutant H64V/V67R, replacing the H-bond from His64 by one 
from Arg67 in the hydrophilic side of heme, recruits the nitrite ligand and 
adopting an O-binding mode again (Fig. 2-4B) [14]. These results strongly 
support that the H-bond from His64 does play a significant role in the nitrite 
binding mode, at least in horse heart Mb. 
 
 
 
Fig. 2-4. Fo-Fc omit electron density maps (contoured at 3σ) and final models of the 
heme sites of the N-bound nitrite adduct of the ferric Mb H64V (A; PDB ID 3HEP) and 
the O-bound nitrite adduct of the ferric Mb H64V/V67R (B; PDB ID 3HEO). 
 
Our lab then proceeded to determine the structures of a heme-
reconstituted Mb-nitrite, but with heme replaced by a chlorin (FeMPPa, MPPa = 
pyropheophorbide-a methyl ester) (see two structures below) [17].  
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A crystal structure of the product obtained from the insertion of the 
preformed (MPPa)Fe-nitrite into a apoMb displayed a N-binding mode (Fig. 
2-5A). In contrast, an alternate structure, obtained from addition of nitrite to the 
reconstituted MbChl(H2O), was shown to contain the nitrite O-binding mode 
(Fig. 2-5B). Our results demonstrated that both N-binding and O-binding of 
nitrite are possible when the macrocycle heme was replaced by a chlorin 
macrocycle.   
 
  
Fig. 2-5. Fo-Fc omit electron density maps (contoured at 3σ) and final models of the 
heme sites of the N-bound nitrite adduct of the MbChl(NO2) (A; PDB ID 3V2Z) and the 
O-bound nitrite adduct of the MbChl(ONO) (B; PDB ID 3V2V). 
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Based on our lab’s result, we arrived at the tentative conclusion that Mb 
prefers the O-binding mode with nitrite. Also, we concluded that His64 plays an 
important role in the ligand binding mode by donating a H-bond to the nitrite.  
The goals of my research in this area were to (i) determine if the nitrite 
binding modes were species-dependent (e.g., hh Mb vs sw Mb), (ii) to introduce 
additional H-bonding modifications in the Mb distal pocket and examine their 
effects on nitrite binding, and (iii) to determine the crystal structures and 
preferred orientations of the NO products from the nitrite reduction reactions. 
Three mutants were designed. In the H64A mutant, the non-H-bonding 
Ala64 replaces the His64. The H64Q mutant provides a possible hydrogen 
bond by Gln64. The double mutant V68A/I107Y creates more space in the 
pocket by replacing Val68 with Ala68, and contributes an additional hydrogen 
bond from Tyr107 (see the diagram below).  
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2.2 Materials and methods 
2.2.1 Cloning 
The plasmid (pET-28a-wt) containing the gene for recombinant wild-type 
sperm whale myoglobin (wt sw Mb) was kindly provided by Prof. Mario Rivera 
at the University of Kansas. The wt recombinant protein from this plasmid has 
two differences in the sequence compared with native sperm whale myoglobin: 
a Met residue added to the N-terminus as a result of expression by E. coli, as 
well as a mutation made at Asp122 to Asn122 due to an error in the former’s 
sequence determination [18].  
Mutagenesis was performed using the Quick-Change method 
(Stratagene). The steps included (i) PCR with designed primers of mutants 
depending on the wt sw Mb plasmid; (ii) purification of PCR products; (iii) 
digestion of templates with the Dpn1 enzyme; (iv) transformation of the 
products into DH5α (E. coli) competent cells; (v) purification of new plasmids. 
The mutants were confirmed by sequencing. For the double mutant 
V68A/I107Y, the V68A mutation was performed first, followed by the I107Y 
mutation.  
2.2.2 Expression and purification of the sw Mb proteins 
The wt and mutant H64Q proteins were expressed in E. coli BL21(DE3) 
and purified as described by Springer and Sligar [19] with slight modifications. 
The resuspended cells were sonicated in 50 mM Tris, 1mM EDTA, pH 7.4, and 
appropriate amounts of DNase, RNase, PMSF, and Pepstatin A. The Mb was 
obtained pure with a 90% ammonium sulfate (AS) precipitation, after initially 
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removing other proteins with 60% AS. Dialysis was performed to remove AS 
using a low salt buffer (20 mM Tris, 1 mM EDTA, 40 mM NaCl, pH 7.4). The 
sample was subjected to DEAE (Sigma) anion exchange chromatography and 
eluted using a linear salt gradient from low salt (40 mM NaCl) to high salt (1 M 
NaCl). A G50 (Sigma) gel filtration with 20 mM Tris, 1 mM EDTA, pH 7.4 was 
the last purification step to obtain samples pure enough for crystallization. 
The purification methods for the H64A and V68A/I107Y proteins were 
similar to those used for wt and H64Q, except that the DEAE anion exchange 
column was replaced by a CM-32 cellulose (Whatman) cation exchange 
column. The CM-32 column was equilibrated with 100 mM potassium 
phosphate at pH 5.8, and eluted using a linear salt gradient from 0 mM NaCl to 
1M NaCl at the same pH value. The proteins produced from this purification 
procedure contained apo- and heme-bound proteins. In order to obtain 
homogeneous proteins for the following steps, heme reconstitution was 
performed for all four proteins between the ion exchange and gel filtration steps.  
Reconstitution was performed using an excess (15 mM) of heme in 0.1 M 
NaOH which was added slowly dropwise into the protein solution and stirred 
overnight at 4 °C. The final purified protein samples were concentrated to ~20 
mg/ml for hanging-drop crystallization or 60 mg/ml for crystallization by using 
the batch method. Protein concentrations were estimated by measuring the 
absorbance of the heme Soret band at 408 nm using the extinction coefficient 
of metMb (188 mM-1 cm-1) 
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2.2.3 UV-vis and IR spectroscopy of the sw Mb with nitrite and nitric oxide 
Aquamet sw Mb proteins were reacted with sodium nitrite directly to form 
the sw Mb-NO2 complexes. The sw Mb-NO and mutant derivatives were 
generated from the reduction of sw Mb-NO2 by excess dithionite. The reactions 
were examined by UV-vis spectroscopy and infrared spectroscopy.  
UV-vis Spectroscopy 
A Hewlett Packard 8453 spectrophotometer was used to obtain the UV-
vis spectra of the complexes to determine the reaction times and the stabilities 
of the complexes.  The protein samples in 20 mM Tris, 1 mM EDTA, pH 7.4 
were purified as stated above. For all reactions, 10-15 µl of protein (10-20 
mg/ml) were added into 2.5 ml 0.1 M phosphate buffer at pH 7.4 in a cuvette to 
first obtain the metMb spectrum. Next, 5 µl of 1 M sodium nitrite in phosphate 
buffer were added to obtain the spectra of sw Mb-NO2. In order to obtain the 
spectrum of sw Mb-NO, metMb was reduced first by the addition of 5 µl 1 M 
dithionite, followed by the addition of 5 µl of 1 M sodium dithionite into the 
cuvette. The spectra were recorded at different time points. 
Infrared Spectroscopy 
A TENSOR II FTIR spectrometer equipped with BioATR II unit (Bruker) 
and liquid N2 cooled MCT detector was used to obtain the NO (νNO) vibrational 
frequencies in the Mb derivatives. Phosphate buffer (0.1 M, pH 7.4) was used 
for all experiments. Each spectrum was obtained at 22 °C. The background 
spectrum was collected using phosphate buffer. Spectrum 1 was 17 µl of 
sample containing 10 µl of 0.4-0.7 mM protein solution plus 7 µl of buffer. 
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Spectrum 2 was 10 µl of the same protein with the addition of 1 µl of 10 M 
sodium nitrite and after 5 min 6 µl of 1.7 M dithionite was added. The last 
difference spectrum (spectrum 3) upon the formation of Mb-NO complex was 
obtained by subtracting spectrum 2 from spectrum 1. Each spectrum condition 
is listed in Table 2-1. 
 
Table 2-1. Spectra of IR spectroscopy 
 Protein solution NO2
-/dithionite 
Spectrum 1 √  
Spectrum 2 √ √ 
Spectrum 3  √ 
 
 
2.2.4 Crystallization of the ferric sw Mb and mutant proteins 
Crystals of the recombinant myoglobins were grown in AS as described 
by Phillips et al. [20, 21]. For wt, H64Q, and V68A/I107Y, the hanging drop 
vapor diffusion was used with 2.56-3.20 M AS in the well solution containing 
100 mM Tris•HCl, 1 mM EDTA, pH 7.4 or pH 9.0. A 5 µl drop of 20 mg/ml 
protein was mixed with 5 µl of the well solution on a cover slip. The cover slip 
was inverted and sealed over the well and allowed to stand at 20 °C. After the 
drop equilibrated overnight, seeding was performed. The batch method was 
applied for crystallization of the H64A mutant, in which 10-20 µl of 60 mg/ml 
protein was mixed with 3.2 M ammonium sulfate in 100 mM Tris•HCl, 1 mM 
EDTA, pH 9.0 to reach 2.3-2.6 M ammonium sulfate as the final concentration 
in 10.25x64 mm MonojectTM blood collection tubes (COVIDIEN).  
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2.2.5 Preparation of the sw Mb-NO2 and -NO derivatives for X-ray 
crystallography 
Mb-nitrite complexes for X-ray crystallography 
The crystal structures of the metMb-H2O precursors were solved prior to 
ligand soaking. In addition, the structures of deoxy form without any ligands 
(i.e., ferrous Mb) were solved using crystals from the reduction of met forms 
using dithionite. Specifically, the appropriately sized met form crystals were 
transferred into a 4 µl droplet (well solution containing 10% glycerol) on a cover 
slide. The cover slide with the drop was placed in a layer of light mineral oil. 
Solid dithionite was added into the droplet and after ~10 min the color changed 
from red to pink signifying the formation of the ferrous deoxy form of Mb. The 
treated crystals were harvested and stored in liquid nitrogen until used for X-ray 
diffraction data collection. 
The Mb-nitrite complexes were obtained using a similar method as 
described above. A few solid crystalline particles of sodium nitrite were added 
into the droplet to react with the Mb crystals for 20-30 min. The treated crystals 
were harvested using cryo-loops at different time periods and stored in liquid 
nitrogen.  
Mb-NO complex preparation for X-ray crystallography 
After soaking the met form crystals with nitrite for 20-30 min, excess solid 
dithionite was added into the droplet to reduce the ferric sw Mb-NO2 to the 
ferrous sw Mb-NO derivatives. A clear color change from brown to pink was 
observed. The treated crystals were harvested as above.   
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2.2.6 X-ray data collection 
The diffraction data was collected at home source using a Rigaku 
MicroMax 007HF microfocus X-ray generator coupled to a R-AXIS IV++ 
detector or a PILATUS 200K detector (Table 2-2). The data was collected at 
100 K with the Cu Kα radiation (λ = 1.54178 Å) from the generator operated at 
the working condition 40 kV/30 mA.  
 
Table 2-2. Data collection parameters 
 Detector 
Detector 
distance (mm) 
Oscillation 
angles (º) 
Oscillation 
Range (º) 
Exposure 
time (s) 
metwt-H2O PILATUS 35 0.5 116 30 
deoxy wt PILATUS 35 0.5 137 30 
metwt-NO2 R-AXIS IV 130 1 90 300 
metwt-NO R-AXIS IV 110 1 100 300 
metH64A-H2O R-AXIS IV 130 1 90 300 
deoxy H64A PILATUS 35 0.5 135.5 30 
metH64A-NO2 R-AXIS IV 130 0.5 360 120 
metH64A-NO PILATUS 35 0.5 114 30 
metH64Q-H2O PILATUS 35 0.5 106 30 
deoxy H64Q PILATUS 35 0.5 95.5 30 
metH64Q-NO2 PILATUS 35 0.5 360 180 
metH64Q-NO PILATUS 35 0.5 135.5 30 
metV68A/I107Y-H2O PILATUS 35 0.5 360 30 
deoxy V68A/I107Y PILATUS 35 0.5 172 30 
metV68A/I107Y-NO2 R-AXIS IV 120 1 100 300 
metV68A/I107Y-NO PILATUS 35 0.5 176 30 
 
 
2.2.7 Data processing, structure solution and refinement 
The data were processed using iMOSFLM [22] or HKL3000 [23]. The 
output mtz files from iMOSFLM were scaled by Aimless [24]. If HKL3000 was 
used, the sca output file were transformed into MTZ files by Scalepack2mtz as 
implemented in the CCP4 program suite [25]. 
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Initial phases were obtained by molecular replacement using PHASER 
(CCP4) [26]. The starting model used was wt sw Mb (metMb-H2O) at 1.5 Å 
resolution (PDB accessioncode 2MBW) with the heme, sulfates, and water 
molecules removed from the structure. Refinements were performed using 
either Refmac5 (CCP4) or Phenix.refine (PHENIX) [27, 28]. Models were rebuilt 
using COOT [29]. The MolProbity server was used for structure validation [30]. 
The details are described below for each of the structures. 
The figures of the final models for each structure were generated using 
Pymol [31]. 2Fo-Fc electron density maps were initially calculated by Fast 
Fourier Transform (FFT) in the CCP4 software package [32]. The resulting map 
files were converted to CCP4 format files and displayed in Pymol.  Fo-Fc 
electron density maps were generated as follows: (i) a new PDB file in which 
ligands were removed from the heme pocket was initially refined for 5 cycles in 
Refmac5; (ii) the new mtz file that was generated from the first step was input 
into FFT to generate the map that was then displayed in Pymol. This procedure 
was followed for the following structures except when stated otherwise.  
wt Mb-H2O 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.363 to 0.226. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Three sulfate anions were added to the model. The N-
terminal Met residue and the residue Gly153 in C-terminus were omitted due to 
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the lack of electron density. The final R factor and Rfree are 0.144 and 0.193, 
respectively. 
wt Mb deoxy form 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.380 to 0.271. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Two sulfate anions were added to the model. Two 
conformations for each of the sidechains of Leu115, Asn132 and Tyr151 were 
modeled with 50% occupancy each. The N-terminal Met residue and the C-
terminal residue Gly153 were omitted due to the lack of electron density. The 
final R factor and Rfree are 0.149 and 0.201, respectively. 
wt Mb-NO2 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.470 to 0.318. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Three sulfate anions, seven nitrite anions and one glycerol 
were added to the model. Two conformations for each of the sidechains of 
Lys133 and Lys145 were modeled with 50% occupancy each. The final R factor 
and Rfree are 0.148 and 0.187, respectively. 
 wt Mb-NO 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.444 to 0.307. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
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refinement cycles. One sulfate anion, one nitrite anion, one nitric oxide and one 
glycerol molecule were added to the model. The C-terminal residues Gln152 
and Gly153 were omitted due to the lack of electron density. The final R factor 
and Rfree are 0.138 and 0.191, respectively. 
Mb H64A-H2O 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.373 to 0.276. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Six sulfate anions and six glycerol molecules were added to 
the model. Two conformations for each of the sidechains of Lys87, Lys133, and 
Glu136 were modeled with 50% occupancy each. The N-terminal Met residue 
was omitted due to the lack of electron density. The final R factor and Rfree are 
0.138 and 0.167, respectively. 
Mb H64A deoxy form 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.372 to 0.255. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Six sulfate anions and one glycerol molecule were added to 
the model. Two conformations for each of the sidechains of Leu115, Asn132 
and Tyr151 were modeled with 50% occupancy each. The N-terminal Met 
residue was omitted due to the lack of electron density. The final R factor and 
Rfree are 0.148 and 0.171, respectively. 
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Mb H64A-NO2 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.347 to 0.255. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Three sulfate anions, eight nitrite anions and one glycerol 
molecule were added to the model. Two conformations for each of the 
sidechains of Asn122 were modeled with 50% occupancy each. The N-terminal 
Met residue was omitted due to the lack of electron density. The final R factor 
and Rfree are 0.148 and 0.187, respectively. 
Mb H64A-NO 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.334 to 0.245. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Three sulfate anions, seven nitrite anions, one nitric oxide 
and two glycerol molecule were added to the model. Two conformations for 
each of the sidechains of His12, Asn122, and Lys133 were modeled with 50% 
occupancy each. The N-terminal Met residue was omitted due to the lack of 
electron density. The final R factor and Rfree are 0.149 and 0.186, respectively. 
Mb H64Q-H2O 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.348 to 0.254. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Six sulfate anions and three glycerol molecules were added 
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to the model. Two conformations for each of the sidechains of Lys133 and 
Glu136 were modeled with 50% occupancy each. The N-terminal Met residue 
was omitted due to the lack of electron density. The final R factor and Rfree are 
0.139 and 0.168, respectively. 
Mb H64Q deoxy form 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.361 to 0.253. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Six sulfate anions and five glycerol molecules were added to 
the model. Two conformations for each of the sidechains of Lys87 and Lys133 
were modeled with 50% occupancy each. The N-terminal Met residue was 
omitted due to the lack of electron density. The final R factor and Rfree are 0.147 
and 0.183, respectively. 
Mb H64Q-NO2 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.294 to 0.222. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Two sulfate anions, ten nitrite anions and two glycerol 
molecules were added to the model. Two conformations for each of the 
sidechains of Lys16, Val68 and Asn122 were modeled with 50% occupancy 
each. The N-terminal Met residue was omitted due to the lack of electron 
density. The final R factor and Rfree are 0.160 and 0.201, respectively. 
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Mb H64Q-NO 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.317 to 0.240. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Three sulfate anions, seven nitrite anions, one nitric oxide 
and three glycerol molecules were added to the model. Two conformations for 
each of the sidechains of Asn122 were modeled with 50% occupancy each. 
The N-terminal Met residue was omitted due to the lack of electron density. The 
final R factor and Rfree are 0.153 and 0.193, respectively. 
Mb V68A/I107Y-H2O 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.371 to 0.240. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Three sulfate anions and one glycerol molecule were added 
to the model. The C-terminal residues Gln152 and Gly153 were omitted due to 
the lack of electron density. The final R factor and Rfree are 0.160 and 0.199, 
respectively. 
Mb V68A/I107Y deoxy form 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.384 to 0.244. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. Two sulfate anions and two glycerol molecules were added 
to the model. The N-terminal Met residue and the C-terminal residue Gln152 
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and Gly153 were omitted due to the lack of electron density. The final R factor 
and Rfree are 0.186 and 0.250, respectively. 
Mb V68A/I107Y-NO2 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.455 to 0.276. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. One sulfate anion and two nitrite anions were added to the 
model. The N-terminal Met residue and the C-terminal residues Gln152 and 
Gly153 were omitted due to the lack of electron density. The final R factor and 
Rfree are 0.175 and 0.247, respectively. 
Mb V68A/I107Y-NO 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.433 to 0.282. Ligands and water were added to the 
model depending on the Fo-Fc electron density map in the subsequent 
refinement cycles. One sulfate anion, one nitrite anion and one nitric oxide were 
added to the model. The N-terminal Met residue was omitted due to the lack of 
electron density. The final R factor and Rfree are 0.157 and 0.205, respectively. 
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2.3 Results 
2.3.1 Expression and purification of wt and mutant sw Mbs 
The four proteins were expressed in E. coli. The mutant H64A and H64Q 
proteins have higher and more stable expression levels (~100 mg/L) compared 
with those of the wt and the double-mutant V68A/I107Y proteins (~10 mg/L). In 
order to get purer proteins, the H64A and V68A/I107Y mutants were passed 
through a CM cation exchange column rather than a DEAE anion exchange 
column to obtain pure samples.  
2.3.2 UV-vis spectroscopy of sw Mb-NO2 and -NO derivatives 
2.3.2.1 The UV-vis characterization of wt sw Mb-NO2 and -NO derivatives 
In a manner similar to that reported for the reaction of ferric sw Mb with 
nitrite [33, 34], the reaction of wt sw Mb with sodium nitrite caused a slight red-
shift at the Soret band from 408 nm to 409 nm (Fig. 2-6A). This red-shift was 
also observed in the Q region (450-600 nm) with a decrease at the band at 500 
nm [33]. The addition of dithionite to met wt Mb caused a quick disappearance 
of the 408 nm band and the 500 nm band, and the appearance of new bands at 
433 nm and 556 nm, representing the formation of deoxy wt Mb (Fig. 2-6B and 
C) [19, 35]. The subsequent addition of nitrite to deoxy Mb resulted in a gradual 
shift of the Soret band from 433 nm to 421 nm (Fig. 2-6B), with formation of two 
bands at 549 nm and 582 nm, which agrees with the previously-reported UV-vis 
data for the wt sw Mb-NO complex in solution [36]. The changes between the 
maximum absorbance of wt Mb-NO at 421 nm and the isobestic point 457 nm 
are plotted in the inset in Fig. 2-6B. According to the data obtained, the 
formation of the Mb-NO complex reached completion after ~6.5 mins.  
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Fig. 2-6. UV-vis spectral monitoring of the reactions of wt sw Mb with nitrite and nitric 
oxide. A) changes after addition of nitrite; B) changes after addition of dithionite to ferric 
sw Mb followed by addition of nitrite as well as the plot of ΔAbs(421-457) against time; 
C) UV-vis spectra of the three forms of wt sw Mb (aquamet, deoxy and NO) with the 
enlarged Q region. Conditions: 0.1 M phosphate buffer, pH 7.4, [protein] = 1.8-7.4 µM, 
[nitrite] in A) = 40 mM, [dithionite] = 5 mM, [Nitrite] in B) and C) = 4 mM. 
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2.3.2.2 The UV-vis characterization of wt sw Mb H64A-NO2 and -NO 
derivatives 
The addition of nitrite to aquamet H64A did not result in a significant 
change of the UV-vis spectrum. The maximum absorbance of H64A-NO2 is still 
located at 408 nm in the Soret region, but we do still observe peak profile 
changes in the Soret and Q regions (Fig. 2-7A). In the inset of Fig. 2-7A, the 
aquamet form of H64A has an absorbance of 505 nm in the Q band which is 
different from the aquamet form of wt which has absorbance at 500 nm. The 
reaction of H64A and nitrite results in a small decrease of the band at 505 nm 
(see the solid line of the inset in Fig. 2-7A). 
Dithionite reduced the aquamet H64A to the deoxy form resulting in a 
shift of the Soret band to 433 nm (Fig. 2-7B and C), and a Q band at 556 nm 
(inset in Fig. 2-7C). This reduction by dithionite was followed by the addition of 
nitrite, resulting in the formation of the NO-complex where NO coordinates with 
heme iron. The reaction reached completion after ~17 mins (see the inset in 
Fig. 2-7B). The spectrum of H64A-NO displayed a similar spectrum as the wt-
NO derivative, with an absorbance at 421 nm in the Soret region, and 547 nm 
and 582 nm in the Q region (Fig. 2-7C). 
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Fig. 2-7. UV-vis spectral monitoring of the reactions of sw Mb H64A with nitrite and 
nitric oxide. A) changes after addition of nitrite; B) changes after addition of dithionite to 
ferric sw Mb followed by addition of nitrite as well as the plot of ΔAbs(421-455) against 
time; C) UV-vis spectra of the three forms of sw Mb H64A (aquamet, deoxy and NO) 
with the enlarged Q region. Conditions: 0.1 M phosphate buffer, pH 7.4, [protein] = 2.7 
µM, [nitrite] in A) = 40 mM, [dithionite] = 5 mM, [Nitrite] in B) and C) = 4 mM. 
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2.3.2.3 The UV-vis characterization of wt sw Mb H64Q-NO2 and -NO 
derivatives 
We were intrigued that the Soret band of ferric H64Q shifted from 408 
nm to 412 nm when the protein was reacted with nitrite, because this shift is 
much larger than that observed for the other three proteins (Fig. 2-8A). Similar 
to that seen for H64A, the ferric H64Q protein also has an absorbance at 505 
nm in the Q region which flattens upon addition of nitrite (inset in Fig. 2-8A). 
There are no large differences for the spectra obtained for the H64Q 
deoxy and H64Q-NO complex when compared with those obtained for the wt 
and H64A derivatives. The deoxy form of H64Q (from the reduction of aquamet 
H64Q by dithionite) absorbs at 434 nm in the Soret region (Fig. 2-8B and C), 
and 558 nm in the Q region (inset in Fig. 2-8C). The reaction of deoxy H64Q 
with nitrite yields H64Q-NO which absorbs at 421 nm, 548 nm, and 581 nm 
(Fig. 2-8C). The formation of the H64Q-NO derivative reached completion after 
~30 mins (inset in Fig. 2-8B). 
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Fig. 2-8. UV-vis spectral monitoring of the reactions of sw Mb H64Q with nitrite and 
nitric oxide. A) changes after addition of nitrite; B) changes after addition of dithionite to 
ferric sw Mb followed by addition of nitrite as well as the plot of ΔAbs(421-457) against 
time; C) UV-vis spectra of the three forms of sw Mb H64Q (aquamet, deoxy and NO) 
with the enlarged Q region. Conditions: 0.1 M phosphate buffer, pH 7.4, [protein] = 1.5 
µM, [nitrite] in A) = 40 mM, [dithionite] = 5 mM, [Nitrite] in B) and C) = 4 mM. 
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2.3.2.4 The UV-vis characterization of wt sw Mb V68A/I107Y-NO2 and -NO 
derivatives 
A slight red-shift was observed in the UV-vis spectrum after addition of 
nitrite to the aquamet ferric double mutant V68A/I107Y (Fig. 2-9A). The 
maximum absorbance at 407 nm did not change, but a decrease of the 494 nm 
in the Q region was observed (inset in Fig. 2-9A). Reduction of ferric 
V68A/I107Y by dithionite results in a rapid shift of the Soret band from 407 nm 
to 432 nm which is due to the formation of ferrous deoxy V68A/I107Y (Fig. 2-9B 
and C). Subsequent addition of nitrite caused the new band to gradually shift 
from 432 nm to 420 nm, which represents formation of the complex 
V68A/I107Y-NO (Fig. 2-9B). During the formation of this NO complex, an 
isosbestic point at 474 nm was observed compared to its position at 457 nm in 
the wt protein, 455 nm in the H64A protein, and 457 nm in the H64Q protein.  
For the spectra of V68A/I107Y-NO shown in Fig. 2-9B and C, the 
spectrum of deoxy form was obtained from adding 5 mM dithionite to reduce the 
metMb precursor. Followed by this, nitrite in phosphate buffer was added to 
reach a final 4 mM concentration, and the spectra were recorded at different 
time points. 
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Fig. 2-9. UV-vis spectral monitoring of the reactions of sw Mb V68A/I107Y with nitrite 
and nitric oxide. A) changes after addition of nitrite; B) changes after addition of 
dithionite to ferric sw Mb followed by addition of nitrite as well as the plot of ΔAbs(420-
474) against time; C) UV-vis spectra of the three forms of sw Mb V68A/I107Y 
(aquamet, deoxy and NO) with the enlarged Q region. Conditions: 0.1 M phosphate 
buffer, pH 7.4, [protein] = 2.2 µM, [nitrite] in A) = 40 mM, [dithionite] = 5 mM, [Nitrite] in 
B) and C) = 4 mM. 
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2.3.3 Crystallization of wt and mutant sw Mbs 
The wt and V68A/I107Y Mbs were crystallized from hanging drops 
containing 2.56 M AS, 100 mM Tris•HCl, 1mM EDTA at pH 7.4. Although 
crystals of these proteins were also obtained at pH 9.0, the crystal at pH 7.4 
had better morphologies. For the H64Q mutant, suitable crystals were obtained 
from a broad concentration range of AS (2.56 to 3.2 M) either at pH 7.4 or pH 
9.0. The fourth protein, namely H64A Mb, was crystallized using the (overnight) 
batch method. Photos of crystals of the four proteins are shown below (Fig. 
2-10). 
 
 
Fig. 2-10. Crystals of the sw Mbs. A) wt sw Mb at pH 7.4; B) sw Mb H64A at pH 9.0; C) 
sw Mb H64Q at pH 7.4; D) sw Mb H64Q at pH 9.0; E) sw Mb V68A/I107Y at pH 9.0. 
 
2.3.4 The sw Mb-NO2 derivatives from the nitrite soaking method 
Following our group’s earlier process at obtaining horse heart Mb-NO2 
derivatives, the ferric sw Mb protein crystals were soaked with nitrite. No cracks 
in the crystals were observed. The droplets containing the crystals remained 
clear throughout the entire reaction, and no bubbles (e.g., due to generated 
NO) or precipitates over the course of the soaking process were observed.  
A B C D E 
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Care was taken to keep the pH of soaking solutions the same as the pH 
of the pre-formed ferric Mb crystals; namely, pH 7.4 for wt and V68A/I107Y, pH 
9.0 for H64A and H64Q. 
 
2.3.5 The sw Mb-NO derivatives from the reactions with sodium nitrite and 
dithionite 
Following the introduction of nitrite to the ferric sw Mbs as described 
earlier, dithionite was added into the droplet to generate the complexes sw Mb-
NO. The crystals changed color from brown to pink during the 10 min reaction 
of sw Mb-NO2 with dithionite. 
 
2.3.6 Crystallographic results of sw Mb with nitrite and nitric oxide 
The data collection, data processing, and refinement statistics of 16 
structures, including the met (ferric), deoxy, nitrite, and NO derivatives are 
shown in Table 2-3. Of these structures, six structures have been previously 
published or deposited in the PDB database by others: aquamet wt (native 
protein [37],  PDB ID 2MBW for the recombinant protein [38]) , deoxy wt, wt-NO 
(PDB ID 1HJT and 1JDO ) [39], aquamet H64A (PDB ID 102M) [21], aquamet 
H64Q (PDB ID 2MGH) [18], and deoxy H64Q (2MGG) [18]. The structural 
comparisons in this chapter will use our own data for these structures. Each of 
the complexes will be described in detail below.  
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2.3.6.1 The structural characterization of wt sw Mb with nitrite and nitric 
oxide 
X-ray diffraction data for the wt sw Mb-NO2 was collected at the OU 
MCL, and the structure was solved to 1.85 Å resolution. Nitrite was soaked into 
crystals of the met form of wt Mb as described in the methods section. As 
shown in Fig. 2-11A, C and E, the nitrite ligand is coordinated to the Fe atom of 
heme in the distal pocket, and interacts with heme iron via the O-binding mode 
as observed by us previously in mammalian Mb or Hb [12-14]. The nitrite sits 
vertically in the distal pocket with a distance of 2.0 Å between the heme iron 
atom and oxygen atom (O1) of nitrite (named as Fe-ONO in Table 2-4). The 
trans axial distance between Fe and Nε of His93 is also 2.0 Å (named as Fe-Nε 
(His93) in Table 2-4). The O1 atom is aligned along Fe-Nε(His93) bond with an 
angle of 171°. The bent nitrite linkage is oriented towards the hydrophobic side 
of the heme pocket with an angle of 107° (∠O1-N-O2 in Table 2-4, O2 is the 
terminal oxygen atom). The nitrite ∠N-O1-Fe angle is 105°. 
The nitrite ligand was modeled in the distal pocket with 100% occupancy. 
The His64 residue helps to stabilize the nitrite ligand in the distal pocket via a 
H-bonding interaction. The distance between the Nε atom of His64 and the 
nitrite O2 atom (not bound to Fe) of nitrite is 3.2 Å, whereas the distance 
between the Nε atom and O1 atom (bound to Fe) is 2.8 Å (Fig. 2-11A). The 
nitrite ligand is in close van der Waals contact with Val68: both nitrite N and O1 
atoms have distances of ~3.3 Å to Cγ2 of Val68, but O2 is slightly farther away 
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from Cγ2 with a distance of 3.4 Å. Selected structural data are listed in Table 
2-4.  
 
 
Fig. 2-11. Crystal structures of wt sw Mb-NO2 and -NO. A-B) final models of the heme 
pockets of wt-NO2 and -NO; C-D) 2Fo-Fc electron density maps (contoured at 1 σ) of 
the heme pockets in wt-NO2 and -NO; E-F) the Fo-Fc omit electron density maps 
showing the nitrite (contoured at 3 σ) and NO ligands (contoured at 3 σ) in the 
complexes. 
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The wt-NO complex structure was obtained from the nitrite/dithionite 
method. Specifically, nitrite was soaked into the crystals of the met form 
followed by dithionite addition that reduced both nitrite to NO and FeIII to FeII.  
As seen in Fig. 2-11B, D and F, the NO coordinates to Fe in a direction towards 
the hydrophobic side of porphyrin and the interior of the protein. The nitrosyl N-
atom is situated along the Fe-Nε(His93) axis (174°). The N atom of the bound 
NO is closer to the Nε of His64 (3.1 Å) than the O atom is (3.5 Å). The NO 
ligand stays in close van der Waals contact with Val68. The O atom of NO is 
3.2 Å away from Cγ2(Val68), whereas the nitrosyl N atom is 3.3 Å away from 
Cγ2(Val68). 
2.3.6.2 The structural characterization of sw Mb H64A with nitrite and 
nitric oxide 
Both complexes, H64A-NO2 and H64A-NO, were crystallized and their 
structures solved (Fig. 2-12). We previously noted the importance of the His64 
residue for directing the O-binding mode of nitrite in the distal pocket of Mb [40]. 
For example, the crystal structure of horse heart Mb H64V-NO2 displayed a 
weak N-binding mode due to the replacement of the H-bonding His64 residue 
by valine [14]. Surprisingly, our sperm whale H64A-NO2 complex has a similar 
structure as wt-NO2, where nitrite binds to heme iron with an O-binding mode 
rather than switching to N-binding as observed in the horse heart Mb H64V 
derivative (Fig. 2-12A, C, and E). Further description is provided in the 
discussion section.  
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Fig. 2-12. Crystal structures of sw Mb H64A-NO2 and -NO. A-B) final models of the 
heme pockets of H64A-NO2 and -NO; C-D) 2Fo-Fc electron density maps (contoured at 
1 σ) of the heme pockets in H64A-NO2 and -NO; E-F) the Fo-Fc omit electron density 
maps showing the nitrite (contoured at 3 σ) and NO ligands (contoured at 3 σ) in the 
complexes. 
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Similar to that seen in wt-NO2, the nitrite ligand in the H64A-nitrite 
derivative also bends towards the hydrophobic side of the heme, but 
surprisingly, it is more bent with an angle of 99° (c.f., 107° in wt-NO2). Other 
structure data are listed in Table 2-4. The O1 atom of nitrite is almost aligned on 
the Fe-Nε(His93) axis with an O1-Fe-Nε(H93) angle of 174°. Interestingly, since 
His64 was replaced by Ala, and in order to stabilize the nitrite ligand, the protein 
recruited water molecules to build a H-bond ‘bridge’ to stabilize the ligand in the 
distal pocket (Fig. 2-12A). The distance between the first water (O-atom) 
molecule, closest to nitrite, and the O1 and O2 atoms of nitrite are 2.9 Å and 3.3 
Å, respectively. The nitrite maintain a close van der Waals contact with Phe43 
(instead of Val68) with a distance of 3.5 Å between the O2 atom of nitrite and 
the Cζ of Phe43, since Val68 has now flipped from the horizontal to a vertical 
orientation.  
The NO ligand in H64A-NO has an orientation that is clearly different 
from the wt-NO structure, in that it now points to the hydrophilic side of 
porphyrin rather than the hydrophobic side (Fig. 2-12B, D, and F).  The N-atom 
of NO is on the Fe-Nε(His93)  axis (173°, see Table 2-4). The H64A-NO 
derivative also recruits three water molecules to build up a H-bond bridge which 
further stabilizes the NO ligand (Fig. 2-12B). The O atom of NO ligand forms a 
strong H-bond with the closest water molecule with a distance of 2.5 Å. In 
contrast to the H64A-NO2 derivative, the sidechain of Val68 did not flip 
orientation, thus the NO ligand still keeps a close van der Waals contact with 
Val68. The N and O atoms of the NO ligand are 3.0 Å and 3.2 Å, respectively, 
from the Cγ2 atom of Val68.  
54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
T
a
b
le
 2
-4
. 
S
e
le
c
te
d
 s
tr
u
c
tu
ra
l 
p
a
ra
m
e
te
rs
 f
o
r 
th
e
 M
b
-N
O
2
 a
n
d
 –
N
O
 d
e
ri
v
a
ti
v
e
s
 
d
2
* 
(Å
) 
3
.2
 
3
.3
 
3
.3
 
3
.1
 
d
4
* 
(Å
) 
3
.5
 
2
.5
 
2
.5
 
3
.1
 
* 
d
1
, 
d
2
, 
d
3
 a
n
d
 d
4
 a
re
 s
h
o
w
n
 i
n
 t
h
e
 s
c
h
e
m
e
 b
e
lo
w
. 
 
 
d
1
* 
(Å
) 
2
.8
 
2
.9
 
2
.9
 
2
.8
 
d
3
* 
(Å
) 
3
.1
 
—
 
—
 
2
.9
 
∠
O
1
-F
e
-N
ε(
H
9
3
) 
(º
) 
1
7
1
 
1
7
4
 
1
7
6
 
1
7
3
 
∠
N
-F
e
-N
ε(
H
9
3
) 
(º
) 
1
7
4
 
1
7
3
 
1
7
5
 
1
7
9
 
∠
O
1
-N
-O
2
 
(º
) 
1
0
7
 
9
9
 
1
0
5
 
1
1
8
 
—
 
—
 
—
 
—
 
—
 
∠
F
e
-O
1
-N
 
(º
) 
1
0
5
 
1
1
2
 
1
2
3
 
1
1
7
 
∠
F
e
-N
-O
 
(º
) 
1
3
8
 
1
1
5
 
1
2
2
 
1
4
2
 
N
-O
2
 
(Å
) 
1
.3
 
1
.3
 
1
.2
 
1
.4
 
—
 
—
 
—
 
—
 
—
 
O
1
-N
 
(Å
) 
1
.2
 
1
.3
 
1
.3
 
1
.2
 
N
-O
 
(Å
) 
1
.3
 
1
.2
 
1
.2
 
1
.3
 
F
e
- 
N
ε(
H
9
3
)  
(Å
) 
2
.0
 
2
.1
 
2
.1
 
2
.1
 
F
e
- 
N
ε(
H
9
3
)  
(Å
) 
2
.2
 
2
.2
 
2
.3
 
2
.1
 
F
e
-O
N
O
  
(Å
) 
2
.0
 
2
.1
 
2
.0
 
2
.0
 
F
e
-N
O
 
(Å
) 
1
.8
 
2
.0
 
2
.0
 
2
.0
 
 
w
t-
N
O
2
 
H
6
4
A
-N
O
2
 
H
6
4
Q
-N
O
2
 
V
6
8
A
/I
1
0
7
Y
-N
O
2
 
 
w
t-
N
O
 
H
6
4
A
-N
O
 
H
6
4
Q
-N
O
 
V
6
8
A
/I
1
0
7
Y
-N
O
 
55 
 
2.3.6.3 The structural characterization of sw Mb H64Q with nitrite and 
nitric oxide 
The nitrite sits in the Mb H64Q distal pocket in a similar conformation as 
that seen of the above two proteins (Fig. 2-13A, C, and E). The distances 
between the O1 and O2 atoms of nitrite and the Nε atom of Gln64 are 2.9 Å and 
3.3 Å, respectively, with a H-bond between the nitrite O1 atom and Nε(Gln64). 
In general, the nitrite remains vertical to the heme plane, but forms a wider Fe-
O1-N angle of 123° compared with the related angle in the wt (105°) and H64A 
(112°) proteins (Table 2-4). The O1 atom is almost co-linear with the Fe-
Nε(His93) axis with an angle of 176° (Table 2-4). Two alternative conformations 
of the sidechain of Val68, horizontal and vertical, were modeled and this 
disorder is most likely due to the close van der Waals contact with the nitrite 
ligand. 
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Fig. 2-13. Crystal structures of sw Mb H64Q-NO2 and -NO. A-B) final models of the 
heme pockets of H64Q-NO2 and -NO; C-D) 2Fo-Fc electron density maps (contoured at 
1 σ) of the heme pockets in H64Q-NO2 and -NO; E-F) the Fo-Fc omit electron density 
maps showing the nitrite (contoured at 3 σ) and NO ligands (contoured at 3 σ) in the 
complexes. 
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In the H64Q-NO derivative, the Gln64 residue plays a similar role as 
His64 in the wt protein. As expected, just as in the nitrite complex, it participates 
in a H-bond with the NO ligand. However, Gln64 forms a H-bond with the 
nitrosyl O atom of NO rather than the N atom, which is unusual in hemeprotein-
NO structures. In this H64Q-NO complex, NO points towards the hydrophilic 
side of the porphyrin rather than the hydrophobic side, probably due to the 
strong H-bond (2.5 Å) with Gln64 (Fig. 2-13C and D). Other structural data are 
listed in Table 2-4. The N atom from NO formed an angle of 175° with the Fe-
Nε(His93) bond. The NO ligand keeps a close van der Waals contact with 
Val68, and both atoms of NO (N and O atoms) have equal distances with the 
the Cγ2 atom of Val68. 
2.3.6.4 The structural characterization of sw Mb V68A/I107Y with NOx 
Surprisingly and contrary to our expectation, the mutation of Ile107 to Tyr 
in the distal pocket did not change the nitrite binding mode; it remained O-
bound to Fe. The ∠O1-N-O2 angle of 118° is wider than those seen in the 
other three proteins (Table 2-3). The nitrite ligand keeps in close van der Waals 
contact with the nearby Phe43 and Ala68 residues. The closest atom distances 
between nitrite and these two residues are all 3.4 Å. It is unlikely that Tyr107 
participates in a H-bond with the nitrite ligand since the closest distance (O1 of 
nitrite and Oη of Tyr107) is 3.5 Å. The O1 and O2 atom of nitrite are 2.8 Å and 
3.1 Å, respectively, from the Nε(His64) atom. 
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Fig. 2-14. Crystal structures of sw Mb V68A/I107Y-NO2 and -NO. A-B) final models of 
the heme pockets of V68A/I107Y-NO2 and -NO; C-D) 2Fo-Fc electron density maps 
(contoured at 1 σ) of the heme pockets in V68A/I107Y-NO2 and -NO; E-F) the Fo-Fc 
omit electron density maps showing the nitrite (contoured at 3 σ) and NO ligands 
(contoured at 3 σ) in the complexes. 
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The nitrosyl complex of this double mutant V68A/I107Y was also 
obtained. The resulting FeNO moiety is more like that of the wt, with NO 
pointing towards the hydrophobic side of the porphyrin. The distance between 
the O atom of NO and the Nε(His64) atom is 2.9 Å, which is farther than the 
distance between the N atom of NO and the Nε(His64). Tyr107 is not involved in 
a H-bond with the NO ligand since the distance between the O atom of NO and 
the Oη of Tyr107 is too long (4.2 Å). Except for His64, the closest contact with 
other distal residues is 3.6 Å, namely between the O atom of NO and the 
Cβ(Ala68) atom.  
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2.4 Discussion 
2.4.1 The O-binding mode of nitrite holds up surprisingly well in sw Mb 
and its mutants. 
The preferred but unusual O-binding of nitrite to Mb is more definite than 
we thought. The O-binding mode holds up surprisingly well even in the 
V68A/I107Y double mutant which was predicted by us to display the N-binding 
mode due to two possible H-bonds at opposite sides of nitrite (compare with 
Fig. 2-1). The H64A mutant lacking a distal pocket H-bond from His64 holds the 
nitrite ligand with an O-binding mode as well, which is surprisingly different from 
what we observed previously with hh Mb-NO2 H64V [14]. 
Val68 may play an important role in the binding of nitrite and Mb. 
When necessary, the sidechain of Val68 can change its conformation to 
accommodate the nitrite ligand. In most of the complex structures, the nitrite 
and NO ligands keep in close van der Waals contact with Val68, except for the 
double mutant V68A/I107Y where the Val68 was mutated to Ala. In the 
structure of H64A-NO2, the sidechain of Val68 flipped from a horizontal to a 
vertical conformation due to the interaction between the nitrite and Val68 (Fig. 
2-12A, C, and E). Another example is H64Q-NO2 in which the sidechain of 
Val68 was partially pushed from its original horizontal position to a vertical 
position (Fig. 2-13A, C, and E). The conformational change of Val68 is not 
observed in the NO complexes, since NO is smaller and has less steric effect 
than nitrite. Val68 can accordingly adjust its conformation when the nitrite 
interacts with Mb, and may affect the binding of nitrite to Mb. 
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Water molecules can replace the distal pocket H-bonds lost in Mb. 
The H64A mutant, with no H-bond from the distal pocket residues, 
recruits three water molecules in the distal pocket to form a “water bridge” 
which contribute to a “replacement” H-bond bridge with the nitrite ligand (Fig. 
2-12A, C, and E). This is probably the reason why the nitrite still keeps O-
binding mode in the H64A-nitrite derivative. Even with an omitted H-bond from 
His64, water molecules can remedy the H-bonds lost to stabilize the ligand.  
In fact, this “water bridge” also helps to stabilize the coordinated water 
molecule with heme iron in the aquamet H64A, which was also seen in 
previously published ferric mutant sw Mb H64G-H2O, but not in the H64V and 
H64L mutants [18]. The stable coordinated water with iron in aquamet H64A-
H2O may also account for the similar absorbance of 408 nm of the Soret band 
between wt and H64A.   
 
2.4.2 The 64th residue may affect the orientation of the ligand. 
There are two different orientations of NO ligands in the four proteins 
(Fig. 2-15). The NO in the wt and V68A/I107Y derivatives points to the 
hydrophobic side of porphyrin (red and yellow in Fig. 2-15) which is the 
dominant conformation in both sw Mb or hh Mb [13, 15, 39, 41], but it switches 
to the hydrophilic side of porphyrin in sw H64A and sw H64Q (blue and purple 
in Fig. 2-15). The significant difference is the 64th residue for these two groups 
of proteins. The wt and V68A/I107Y proteins have a His reside in the 64th 
position, whereas the H64A and H64Q mutants do not. We thus clearly 
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observe, for the first time, that the 64th residue affects the orientation of the NO 
ligand, in large part due to the fact that the 64th residue usually keeps in close 
contact to the NO ligand via H-bond interactions.  
 
 
 
Fig. 2-15. Comparison of the heme pockets from the four Mb-NO complexes: wt-NO 
(red), H64A-NO (blue), H64Q-NO (purple), and V68A/I107Y-NO (yellow). 
 
 
This is the first reported observation of the hydrophilic orientation of NO 
ligand in hemeprotein-NO derivatives. Selected structural data of the nitrosyl 
his-liganded hemeproteins are listed in Table 2-5. The bound NOs form a broad 
range of ∠Fe-N-O angles from 112° to 180°, with the Fe-N(O) distances ranging 
from 1.5-2.1 Å. The significant range of FeNO conformation suggests the 
influence on the NO ligand by the distal residues through the combination of 
factors including steric and electrostatic effects [13]. 
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Table 2-5. X-ray structural data for the nitrosylated His-liganded heme proteins
a
 
Hemeprotein-NO complexes PDB 
Res 
(Å) 
O.S.
b
 
Fe-N(O) 
(Å) 
N-O (Å) 
∠Fe-N-O 
(°) 
Fe-(LProx) 
(Å) 
ref 
sw Mb 1HJT 1.7 II 1.89 1.15 112 2.18 [39] 
     L29F/D122N sw Mb 1JDO 1.9 II 1.86 1.14 127 2.31 [39] 
sw Mb wt  1.7 II 1.8 1.3 138 2.2 
c 
     H64A  1.78 II 2.0 1.2 115 2.2 
     H64Q  1.78 II 2.0 1.2 122 2.3 
     V68A/I107Y  1.79 II 2.0 1.3 142 2.1 
hh Mb (MS xafs)   II 1.75 1.12(2) 150(2) 2.05 [42] 
   III 1.68(2) 1.13(2) 180(4) 2.04 [42] 
hh Mb 1NPF 1.9 II 2.0 1.1 147 2.1 [41] 
hh Mb (nitrite/dithionite) 2FRJ 1.3 II 1.9 1.2 144 2.1 
[13] 
hh Mb (NO gas) 2FRK 1.3 II 2.1 1.2 121 2.1 
Tuna Mb 2NX0 0.95 II 1.7 1.2 134 2.1 [43] 
NP1 from Rhodnius prolixus 4NP1 2.3 II 2.06 1.34 120 2.10 
[44] 
   III 2.02 1.32 145 2.0 
NP2 from Rhodnius prolixus 1T68 1.45  1.93 1.38 134 2.10 [45] 
NP4 from Rhodnius proxilus         
    WT (5.6) 1KOI 1.08 III 1.7 1.1 155 1.0 [46] 
    WT (pH 7.4) 1X8N 1.08 II 1.74(2) 1.20(2) 143.8(1.6) 2.06(1) [47] 
    WT (pH 5.6) 1X8O 1.01 III 1.69(1) 1.09(1) 159.1(1.1) 1.994(7) [47] 
    D129A/L130A 1SXX 1.0 III 1.60(2) 1.35 155(2) 2.05 [48] 
    T121V 1SY1 1.0 III 1.62(2) 1.29 158(2) 2.03 [48] 
    D30N 1SY3 1.0 II 1.78(2) 1.38 132(2) 2.06 [48] 
    D30A 1SXW 1.05 II 1.71(3) 1.35 139(2) 2.09 [48] 
    WT (pH 5.6) 1YWB 0.9 II 1.7 1.1 141 2.1 [49] 
    L133V (pH 5.6) 2AT0 1.00  1.7 1.1 153 2.1 [50] 
    V36A/D129A/L130A 2OFR 1.00  1.7 1.3 136 2.0 [51] 
    D30N/E32Q/D35N 4GRJ 1.15  1.8 (A) 1.2 (A) 142 (A) 2.1 (A) 
[52] 
    1.8 (B) 1.2 (B) 138 (B) 2.1 (B) 
NP7 from Rhodnius prolixus 4XME 1.29  1.8 1.4 124 2.2 [53] 
HO from N. meningitides 1P3U 1.75 II 1.58 1.17 147 2.13 [54] 
HO-1 from rat 1JO2 1.7 II 2.10 1.14 125 2.17 [55] 
Human HO-1          
    WT 1OZW 1.55 II 1.64 1.14 138 2.12 [56] 
    D140A 1OZL 2.59 II 1.49 1.16 148 2.12 [56] 
    Verdoheme 1TWR 2.10  1.83 1.15 151 2.54 
[57] 
    1.98 1.16 150 2.37 
    G139A/R183E 1XK0 2.18 II 2.0 1.2 142 2.1 [58] 
    R183E 1XK3 2.08 II 2.2 1.2 155 2.1 [59] 
HO-2 from Synechocystis sp. 
PCC 6803 
1WOX 2.10 II 2.1 1.1 126 2.1 
[60] 
   II 2.1 1.1 119 2.1 
Lupin legHb 1GDL 1.8 II 1.97 1.35 145 2.19 [61] 
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Table 2-5. X-ray structural data for the nitrosylated His-liganded heme proteins
a
 (cont’d) 
Hemeprotein-NO complexes PDB 
Res 
(Å) 
O.S.
b
 
Fe-N(O) 
(Å) 
N-O 
(Å) 
∠FeNO 
(°) 
Fe-(LProx) 
(Å) 
ref 
Soybean legHb (MS XAFS)   II 1.77 1.12 147 1.98 [42] 
   III 1.68 1.12 173 1.89 [42] 
FixL from B. japonicum 1DP8 2.5 II 1.76 1.14 154 2.10 [62] 
Cyt c from Alcaligenes 
xylosoxidans 
1E85 1.35 II 2.03 1.16 125 5-Coord. 
[63] 
    1.92  132  
Cyt cd1 NiR from P. pantotropha 1AOM 1.8 II 2.0 1.37 128 1.98 [64] 
Cyt cd1 NiR from P. aeruginosa 1NNO 2.65 II 1.8 1.15 140 1.98 [65] 
Cyt c from Rhodobacter 
sphaeroides 
1DW2 2.20 II 1.75 1.42 113 2.23 
[66] 
   II 1.82 1.37 112 2.16 
Horse Hb  2.8  1.74 1.1 145  [67] 
Hb (βcysSNOH) α heme 1BUW 1.8 II 1.75 1.13 131 2.28 [68] 
                           β heme    II 1.74 1.11 123 2.28 [68] 
T-state human Hb α heme 1RPS 2.15 II 1.72 1.13 138 5-coord. 
[69] 
                              β heme   II 1.75 1.15 128 2.25 
T-state human Hb (βcysSNOH) 1RQ4 2.11       
    α heme    1.72 1.15 138 5-coord. 
[69]  
    β heme    1.76 1.17 138 2.19 
T-state human Hb βW37E 1RQA 2.11       
    α heme    1.71 1.16 135 2.24 [69] 
    β heme    1.76 1.18 126 2.19 [69] 
R-state human Hb 4N8T 1.90 II     
[70]     α heme    1.8 1.2 138 2.0 
    β heme    2.1 1.2 125 2.0 
Human Hb with NO from 
prodrug 
5E29 1.85 II     
[71]     α heme    1.6 1.1 143 3.4 
    β heme    - - - - 
Hb from Trematomus bernacchii 4G51 2.5  1.8 1.2 173 2.1 
[72] 
    1.8 1.2 176 2.1 
    1.8 1.1 171 2.1 
    1.8 1.2 178 2.1 
Peroxidase from Arthromyces 
ramosus 
2E3A 1.3  2.0 1.2 125 2.1 [73] 
Peroxidase from Glycine max         
    WT 2GHH 2.01  1.7 1.4 145 2.1 
[74]     W41A 2GHC 1.25  1.8 1.4 129 (alt. 1) 2.1 
    1.8 1.4 117 (alt. 2) 2.1 
H-NOX domain of sGC from  2O0C 2.6  1.8 (A) 
1.1 
(A) 
143 (A) 2.2 (A) 
[75] 
    1.8 (B) 
1.2 
(B) 
157 (B) 2.2 (B) 
a
 Most nitrosylated sites are hexacoordinate of the form (por)Fe(NO)(His), except noted as “5-coord” which stands for 
the pentacoordinate sites. 
b 
Formal oxidation state of iron if known. 
c
 This work. 
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The hydrophilic orientation of NO ligand in the distal pocket of Mb H64A 
and H64Q mutants were stabilized by the H-bonds between the terminal O 
atom of NO and the water bridge in H64A mutant or the Gln64 in H64Q mutant. 
The H-bonds pull NO towards the heme plane, which resulted to more acute 
∠Fe-N-O angles (115° in H64A and 122° in H64Q) than that seen in the wt 
(138°) and V68A/I107Y (142°) proteins (Table 2-4), and also than that in most 
nitrosyl hemeproteins (Table 2-5). Surprisingly, there is no published data to 
show the significant orientation change of NO ligand caused by the distal 
residues. 
The orientational disorder of an NO ligand in an iron porphyrin model is 
known. Silvernail et al. [76] showed that there is no significant difference on the 
potential energy between two (opposite) NO orientations in a series of six-
coordinate iron porphyrinates using computational methods. However, the O 
atoms of NO that rotate from the original position (O1) to the second position 
(O1b) in these iron porphyrinates did experience an energy barrier for rotation. 
Results from their calculations on Mb-NO derivatives (1NPF and 1HJT) were 
used to conclude that the distal pocket locks the NO ligand in only one 
orientation. Further DFT calculation on model [Fe(porphine)(NO)(1-MeIm)] 
systems, however, displayed a low-energy transition with a very small ~1.5 
kJ/mol energy barrier when the O atom of NO ligand rotated from 0°, the initial 
configuration which is coplanar with 1-MeIm (0°) and pointing to a meso carbon 
atom, to 180°. These two positions are “equivalent” to the hydrophobic (0°) and 
hydrophilic (180°) position of NO in our Mb-NO derivatives.  
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These calculated data draw our attention to find other possible factors 
that control the NO orientation in Mb-NO derivatives. All our Mb-NO derivatives 
result from the reduction of Mb-NO2 derivatives. Before the reduction of nitrite to 
nitric oxide, the nitrite ligands in our four Mb proteins are all accommodated in 
the hydrophobic side of distal pocket with O atom bound to Fe. We are 
interesting how the distal pocket controls the setting of the NO ligand into two 
different orientations (H64A and H64Q vs. wt and V68A/I107Y) after the 
reduction of nitrite. Further calculations regarding the formation mechanism of 
different NO orientations are ongoing with our computational collaborator. 
 
2.4.3 The NO ligand was differentiated from HNO by protein IR 
spectroscopy. 
The unique NO orientation in H64A and H64Q resembles that expected 
for HNO bonding with heme iron [77]. If the O atom of NO formed an H-bond 
with the water bridge in H64A or with Gln64 at the hydrophilic side of the 
porphyrin, the N atom of NO has more available space to form the possible Fe-
HNO derivative (see the diagram below). 
 
 
 
67 
In order to more clearly characterize the NO complexes and differentiate 
them from HNO, IR spectroscopy was applied to distinguish these Mb-NO and 
Mb-HNO possibilities by obtaining the vibrational frequency of NO (νNO). For 
example, the νNO of wt Mb-HNO is 1385 cm
-1 which is far from the νNO in ferrous 
Mb-NO at 1613 cm-1 [78, 79]. From the difference spectra in Fig. 2-16, the NO 
vibrational frequencies for the four Mb-NO derivatives are 1650 cm-1 in wt, 1642 
cm-1 in H64A, 1646 cm-1 in H64Q and 1646 cm-1 in V68A/I107Y. Based on these 
results, we confirm that the nitrosyl ferrous Mb (Mb-NO) derivatives rather than 
the Mb-HNO derivatives were formed, since the NO stretching frequencies are 
all within the νNO range of ferrous Mb-NO [78, 79]. 
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Fig. 2-16. Infrared difference spectra showing the NO bands in the four sw Mb-NO 
derivatives: wt (A); H64A (B); H64Q (C); V68A/I107Y (D). The difference spectrum 
upon the formation of Mb-NO complex was obtained from the subtracted spectrum of 
the aquamet Mb and the complex Mb-NO prepared by the nitrite/dithionite method. 
Phosphate buffer (0.1 M, pH 7.4) is the only solvent used throughout the entire 
experiments. The spectra of aquamet Mbs were abtained from 10 µl of 0.4-0.7 mM 
protein solution plus 7 µl of buffer. The spectra of Mb-NO complexes were obtained 
from 10 µl of the same protein with addition of 1 µl 10 M sodium nitrite for 5 min and 
the followed addition of 6 µl 1.7 M dithionite. The complex spectra were recorded within 
1 min at 22 °C.  
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2.4.4 Ferric H64Q Mb shows a significant red-shift when reacted with 
nitrite. 
The spectra of the four aquamet forms of sw Mb show no significant 
differences. The wt absorbs at 408 nm in the Soret region and 500 nm in the Q 
region. H64A and H64Q also have maximum absorbances at 408 nm (Soret 
band) and 505 nm (Q band). The V68A/I107Y showed slightly different 
absorbance at 407 nm (Soret band) and at 494 nm (Q band). No significant 
differences in the spectra were observed when these four sw Mbs were 
reduced to their deoxy form or when they formed the NO derivatives.  When 
reacted with nitrite, the precursor ferric Mbs experienced red-shifts. However, 
H64Q showed a much larger red-shift. Further exploration for H64Q-NO2 is 
needed to ascertain the reaction for this observation.  
Other than the nitrite ligand coordinated with heme iron, the X-ray crystal 
structure of the H64Q-nitrite complex contains additional nitrite ions in the 
Xenon pockets Xe1-3. We note that Xe cavities are also connected to each other 
to form an interior channel (see Fig. 2-17), which agrees with the previous 
reported data [80]. The Xe4 position does not hold a nitrite probably due to the 
quick transfer to Xe2 position [81].  We do also observe two nitrite ions on the 
surface of Mb around the area of Xe3. We propose that the H64Q mutant crystal 
adopts this ligand entry pathway: Xe4→Xe2→Xe1→Xe3. Interestingly, this is the 
only mutant that we observe with nitrite ions in the Xe positions. The relatively 
large red-shift in the reaction of H64Q and nitrite may relate to this special 
interaction mode with nitrite. 
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Fig. 2-17. Overview of the possible nitrite channel (magenta) in sw Mb H64Q-
NO2. The interior surface, calculated by the program HOLLOW and presented 
by Pymol, describes the contour of the nitrite channel. Other than the heme 
binding nitrite, there are other three nitrites trapped in the Xe2, Xe1 and Xe3 
positions. 
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Chapter 3 Organometallic myoglobins: Formation of Fe-carbon 
bonds and distal pocket effects on aryl ligand 
conformations 
 
3.1 Introduction 
Arylhydrazines (ArNHNH2; Ar = aryl) occur in nature and are important 
chemical species in both the agrochemical and pharmaceutical industries [1]. 
Synthetic hydrazines are also prevalent in the general environment [2]. In some 
cases, hydrazines are beneficial components of pharmaceutical drugs such as 
the antidepressant drugs isoniazid and phenelzine, but are also toxic and can 
act as cancer causative agents [1, 2]. For example, the newly FDA-approved 
drug DUOPA® for Parkinson's disease contains the substituted hydrazine 
carbidopa with a known hemolytic anemia side effect. The parent hydrazine 
(NH2NH2) is found in tobacco and tobacco smoke [3]. Hydrazines are also 
present in certain foods. For example, 4-hydroxymethylphenylhydrazine is 
generated as a metabolite from agaritine, a food component from the edible 
commercial mushroom Agaris bisporus [4].  
Phenylhydrazine is toxic to red blood cells [5], and the hemoglobin-
phenylhydrazine reaction has been used to model hemolytic anemia. 
Interactions of substituted hydrazines with human hemoglobin (Hb) may also 
result in hemolysis, Heinz-body formation, and degradation of the protein [6]. 
Related interactions of substituted hydrazines and diazenes (RN=NH) with 
other heme proteins such as myoglobin (Mb) [7-9], cyt P450 [10-12], and 
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catalase [13] have been reported [14]. The generated products often contain 
heme σ-aryl bonds with direct Fe–C(aryl) linkages (Scheme 1) as determined 
by UV-vis and NMR spectroscopy. In some cases, an Fe–to–N(porphyrin) 
migration of the aryl ligand (Scheme 1; right) occurs upon extraction of the 
heme from the protein, or occurs within the heme protein active site (for P450) 
[14].   
 
Scheme 1.  Formation of σ-aryl (middle) and N-aryl (right) products from the reaction 
of arylhydrazines with heme proteins. The heme is designated by the N4Fe plane. 
 
Only two X-ray crystal structures have been reported to date for such 
heme protein σ-aryl species. The crystal structure of the prototypical wild-type 
sperm whale Mb–phenyl complex, obtained from the reaction of Mb with 
phenylhydrazine, was published by Ringe and Ortiz de Montellano and 
coworkers in 1984 [7]. The crystal structure of the P450cam–phenyl complex 
obtained from the reaction with phenyldiazene, was reported by Poulos and 
Ortiz de Montellano and coworkers in 1990 [12]. 
The potential of arylhydrazines to serve as steric probes for heme protein 
active sites has been evaluated [14]. It is well established that the arylhydrazine 
reactions with heme proteins proceed via carbon-based radicals [15, 16] formed 
during aerobic reaction with the protein en route to Fe–C bond formation [17]. 
New X-ray structural data that clarify which aryl C atoms bind to the Fe centers, 
and information regarding preferred aryl ligand orientations from reactions 
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involving substituted arylhydrazines as a function of active site structure are 
thus desirable. 
I have prepared a representative set of derivatives from the reactions of 
arylhydrazines with wild-type and mutant Mbs (see Chapter 2) to determine the 
mode of attachment of the substituted aryl groups to the iron centers [18], and 
the effect of mutating the distal pocket H64 residue on the orientation of the aryl 
ligands. I chose the H64A mutant to remove distal sidechain H-bonding, and the 
H64Q mutant to provide an alternate H-bonding capacity in the heme pocket. 
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3.2 Materials and methods 
3.2.1 Cloning, expression, purification, and crystallization of swMb 
The methodology employed has been described previously in Chapter 2. 
3.2.2 UV-vis spectroscopy of sw Mb-aryl derivatives 
In order to clarify which carbon atom of the aryl group will coordinate with 
heme iron, three reaction precursors, phenylhydrazine and two derivatives (3-
methylphenylhydrazine and 4-chlorophenylhydrazine) were used. The 
arylhydrazines were purchased from Sigma and used without further purification 
(see below).  
HN
NH2
1
2
3
4
5
6
HN
NH2
CH3
HN
NH2
Cl
Phenylhydrazine 3-methylphenylhydrazine 4-chlorophenylhydrazine  
 
Protein solutions were mixed with the arylhydrazines and the reactions 
were monitored using a Hewlett Packard 8453 spectrophotometer. The metMb 
protein samples in 20 mM Tris buffer, 1mM EDTA, pH 7.4 were purified as 
described in Chapter 2. For all the reactions, 10-15 µl of the protein samples (at 
10-20 mg/ml concentration) were added into 2.5 ml of 0.1 M phosphate buffer at 
pH 7.4 in a cuvette to obtain the precursor spectrum. 5 µl aliquots of 0.5 M 
arylhydrazine solutions in phosphate buffer were added and the spectra were 
recorded at different time points. 
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3.2.3 Preparation of sw Mb-aryl derivatives for X-ray crystallography 
Prior to reactions with the arylhydrazine, a representative and suitably-
sized crystal of the metMb-H2O precursor was harvested for X-ray diffraction 
data collection and its crystal structure solved.  The remaining crystals in the 
hanging drop were transferred into a new droplet (4 µl) on a separate cover 
slide that contained a solution of the arylhydrazine (0.0125 M arylhydrazine 
dissolved in 100 mM Tris•HCl, 1 mM EDTA, pH 7.4 or 9.0, and 3.0 M 
ammonium sulfate). In a manner similar to that used for cystallization employing 
the hanging drop vapor diffusion method, the new cover slide containing the 
drop was flipped over and placed on top of a well (in a 24-well format) and 
sealed with grease; the well contained 100 mM Tris•HCl, 1 mM EDTA, pH 7.4 
or 9.0, and 3.0 M ammonium sulfate. This allowed the metMb crystals in the 
drop to react with the arylhydrazines for a longer period (1-14 days at room 
temperature) without drying out. During this process, the cover slides were 
opened every two or three days, and the reaction solutions were exchanged 
with fresh aerated arylhydrazine solutions (and fresh air introduced into the well 
volume) in order to ensure completion of the reactions. The product crystals 
were harvested by cryo-loops daily or weekly, washed by cryosolution (100 mM 
Tris•HCl, 1 mM EDTA, pH 7.4 or 9.0, 3 M ammonium sulfate, 10% glycerol) and 
stored in liquid nitrogen until X-ray diffraction data collection.  The vast majority 
of the product crystals were unusable due to loss in crystallinity as a result of 
the reactions. Indeed, several (patient) attempts were made, >40 per sample, 
until good quality X-ray diffraction data were obtained whose solution revealed 
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the presence of the aryl-liganded swMb-phenyl or swMb-tolyl or swMb-
chlorophenyl products. 
3.2.4 X-ray data collection 
The diffraction data was collected at home source using a Rigaku 
MicroMax 007HF microfocus X-ray generator coupled to a R-AXIS IV++ 
detector or a PILATUS 200K detector. The data was collected at 100 K with the 
Cu Kα radiation (λ=1.54178 Å) from the generator operated at the working 
condition 40 kV/30 mA. The parameters during data collection were set up as 
shown in Table 3-1. 
Table 3-1. Parameters of data collection 
 Detector 
Detector 
distance (mm) 
Oscillation 
angles (º) 
Range 
(º) 
Exposure 
time (s) 
wt-phenyl R-AXIS IV 120 1 180 180 
H64A-phenyl PILATUS 35 0.75 118 30 
H64A-tolyl PILATUS 35 1 180 30 
H64A-chlorophenyl PILATUS 30 1 180 30 
H64Q-phenyl (P21) PILATUS 35 1.25 180 30 
H64Q-tolyl (P21) PILATUS 35 1.5 180 60 
H64Q-chlorophenyl (P21) PILATUS 35 1.25 180 30 
H64Q-phenyl (P6) PILATUS 30 0.5 60 30 
H64Q-tolyl (P6) PILATUS 30 1 142 30 
V68A/I107Y-phenyl PILATUS 35 1.5 230 30 
V68A/I107Y-tolyl PILATUS 35 1 180 30 
 
3.2.5 Data processing, structure solution and refinement 
The data was processed using HKL3000 [19]. The structure factors were 
calculated using the CCP4 program suite [20]. Initial phases were obtained by 
molecular replacement using PHASER (CCP4) [21]. The starting model used 
was wt swMb (metMb-H2O) at 1.5 Å resolution (PDB accession code 2MBW) 
with the heme, water molecules, and ligands removed from the structure. All 
refinements were performed using either Refmac5 (CCP4) or Phenix.refine 
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(PHENIX) [22, 23]. Models were rebuilt using COOT [24].  MolProbity was used 
for structure validation to check for unusual residue conformations contacts; 
details are described below [25]. 
The figures were generated using Pymol [26]. 2Fo-Fc electron density 
maps were initially calculated by Fast Fourier Transform (FFT) in the CCP4 
software package [27]. The resulting map files were converted to CCP4 files 
and displayed in Pymol. In general, each Fo-Fc electron density map was 
generated as follows: (i) a new PDB file in which ligands were removed from the 
pocket was initially refined for 5 cycles in Refmac5; (ii) the new mtz file that was 
generated from the first step was input into FFT to generate the map that was 
then displayed in Pymol. This procedure was followed in the following structures 
except where noted.  
wt Mb-phenyl 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.398 to 0.258. Ligands and water were added to the 
model based on the Fo-Fc electron density maps in the subsequent refinement 
cycles. Phenylheme (heme with a phenyl group attached to Fe) was drawn in 
Jligand (CCP4) to generate the heme-ligand model and the restraint file. One 
phenylheme, one sulfate anion and one glycerol molecule were added to the 
model. 66 water molecules were added iteratively using COOT. The N-terminal 
Met residue, and the residues Gln152 and Gly153 in the C-terminus were 
omitted due to lack of electron density. The final R factor and Rfree were 0.213 
and 0.278, respectively. 
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Mb H64A-phenyl 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.351 to 0.260. Ligands and water were added to the 
model based on the Fo-Fc electron density maps in the subsequent refinement 
cycles. One phenylheme, six sulfate anions, and two glycerol molecules were 
added to the model. 202 water molecules were added iteratively using COOT. 
The anisotropic B values of the Fe atom and tolyl group were refined based on 
the difference peaks around them. Two conformations for each of the 
sidechains of His12, Lys78, Glu109, Asn122, Lys133 and Glu136 were 
modeled with 50% occupancy each. The N-terminal residue Met was omitted 
because of the lack of electron density. The final R factor and Rfree were 0.149 
and 0.187, respectively. 
Mb H64A-tolyl 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.377 to 0.266. Ligands and water were added to the 
model based on the Fo-Fc electron density maps in the subsequent refinement 
cycles. Tolylheme (heme with a tolyl group attached to Fe) was drawn in 
Jligand to generate the ligand model and the restraint file. One tolylheme and 
six sulfate anions were added to the model. 184 water molecules were added 
iteratively using COOT. The anisotropic B values of the Fe atom and tolyl group 
were refined based on the difference peaks around them. Two conformations 
for each of the sidechains of His12, Asn122 and Lys133 were modeled with 
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50% occupancy each. The final R factor and Rfree were 0.153 and 0.179, 
respectively. 
Mb H64A-chlorophenyl 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.358 to 0.277. Ligands and water were added to the 
model based on the Fo-Fc electron density maps in the subsequent refinement 
cycles. Chlorophenylheme (heme with a chlorophenyl group attached to Fe) 
was drawn in Jligand to generate the ligand model and the restraint file. One 
chlorophenylheme, five sulfate anions, and two glycerol molecules were added 
the model. 225 water molecules were added iteratively using COOT. The 
anisotropic B values of the Fe atom and chlorophenyl group were refined based 
on the difference peaks around them. Two conformations for each of the 
sidechains of His12, Glu59, Leu61, Glu109, Arg118 and GLu136 were modeled 
with 50% occupancy each. The N-terminal Met residue was omitted because of 
the lack of electron density. The final R factor and Rfree were 0.152 and 0.192, 
respectively. 
Mb H64Q-phenyl in P21 space group 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.393 to 0.241. Ligands and water were added to the 
model based on the Fo-Fc electron density maps in the subsequent refinement 
cycles. One phenylheme, two sulfate anions, and two glycerol molecules were 
added the model. 88 water molecules were added iteratively using COOT. Two 
conformations for each of the sidechains of Glu4 were modeled with 50% 
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occupancy each. The N-terminal residue Met and the C-terminal residues 
Gln152 and Gly153 were omitted because of the lack of electron density. The 
final R factor and Rfree were 0.188 and 0.234, respectively. 
Mb H64Q-tolyl in P21 space group 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.406 to 0.261. Ligands and water were added to the 
model based on the Fo-Fc electron density map in the subsequent refinement 
cycles. One tolylheme, three sulfate anions and one glycerol molecule were 
added to the model. 119 water molecules were added iteratively using COOT. 
The anisotropic B values of the Fe atom and tolyl group were refined depending 
on the difference peaks around them. Two conformations for each of the 
sidechains of Glu4, Leu29 and Asn132 were modeled with 50% occupancy 
each. The N-terminal Met residue and the C-terminal residues Gln152 and 
Gly153 were omitted because of the lack of electron density. The final R factor 
and Rfree are 0.150 and 0.199, respectively. 
Mb H64Q-chlorophenyl in P21 space group 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.413 to 0.268. Ligands and water were added to the 
model based on the Fo-Fc electron density map in the subsequent refinement 
cycles. One chlorophenylheme, three sulfate anions and one glycerol molecule 
were added to the model. 104 water molecules were added iteratively using 
COOT. The anisotropic B value of the Fe atom was refined based on the 
difference peaks around this central metal atom. Two conformations for each of 
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the sidechains of Glu4, Gln26, Gln64 and Asn132 were modeled with 50% 
occupancy each. The N-terminal Met residue and the C-terminal residues 
Gln152 and Gly153 were omitted because of the lack of electron density. The 
final R factor and Rfree are 0.163 and 0.214, respectively. 
Mb H64Q-phenyl in P6 space group 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.343 to 0.267. Ligands and water were added to the 
model based on the Fo-Fc electron density map in the subsequent refinement 
cycles. One phenylheme, six sulfate anions, and two glycerol molecule were 
added to the model. 192 water molecules were added iteratively using COOT. 
The anisotropic B value of the Fe atom was refined based on the difference 
peaks around this central metal atom. Two conformations for each of the 
sidechains of Gln64, Val68, Lys133 and Glu136 were modeled with 50% 
occupancy each. The N-terminal residue Met was omitted because of the lack 
of electron density. The final R factor and Rfree are 0.171 and 0.210, 
respectively. 
Mb H64Q-tolyl in P6 space group 
Three initial cycles of restrained refinement were run with Phenix.refine, 
and the R factor decreased from 0.339 to 0.214. Ligands and water were added 
to the model based on the Fo-Fc electron density map in the subsequent 
refinement cycles. One tolylheme, six sulfate anions, and one glycerol molecule 
were added to the model. 235 water molecules were added iteratively using 
COOT. The anisotropic B value of the Fe atom was refined based on the 
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difference peaks around this central metal atom. Two conformations for each of 
the sidechains of His12, Leu29, Gln64, Val68, Glu109, Lys133 and Glu136 
were modeled with 50% occupancy each. The N-terminal residue Met was 
omitted because of the lack of electron density. The final R factor and Rfree are 
0.177 and 0.206, respectively. 
Mb V68A/I107Y-phenyl 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.387 to 0.275. Ligands and water were added to the 
model based on the Fo-Fc electron density map in the subsequent refinement 
cycles. One phenylheme, two sulfate anions and one glycerol molecule were 
added to the model. 62 water molecules were added iteratively using COOT. 
The N-terminal Met residue was omitted because of the lack of electron density. 
The final R factor and Rfree are 0.202 and 0.252, respectively. 
Mb V68A/I107Y-tolyl 
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.403 to 0.276. Ligands and water were added to the 
model based on the Fo-Fc electron density map in the subsequent refinement 
cycles. One tolylheme and two sulfate anions were added to the model. 81 
water molecules were added iteratively using COOT. The anisotropic B value of 
the Fe atom was refined based on the difference peaks around this central 
metal atom. The N-terminal residue Met and the C-terminal residues Gln152 
and Gly153 were omitted because of the lack of electron density. The final R 
factor and Rfree are 0.205 and 0.292, respectively. 
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3.3 Results 
3.3.1 Expression, purification and crystallization of sw Mb 
The four proteins were expressed and purified as described in Chapter 2. 
As mentioned in Chapter 2, the H64Q mutant can be crystallized from a broad 
concentration range (2.56 to 3.2 M) of ammonium sulfate (AS) either at pH 7.4 
or pH 9.0. When I was working on this project, I found that the H64Q crystals 
from pH 7.4 and pH 9.0 were actually in different space groups, P21 or P6, 
respectively.  
 
3.3.2 UV-vis spectroscopy of sw Mb-aryl derivatives 
3.3.2.1 The UV-vis characterization of wt sw Mb-aryls 
The reaction of wt sw Mb with phenylhydrazine (PhNHNH2) resulted in a 
decrease of the bands at 408 nm and 500 nm, and the appearance of new 
bands at 433 nm and 540 nm, consistent with that reported previously by Ortiz 
de Montellano for the wt sw Mb-phenyl complex in solution [28, 29] (Fig. 3-1A). 
Apparent isosbestic points were observed at ~425 nm and 486 nm. The 
changes between the new absorbance at 433 nm and the isosbestic point at 
486 nm were plotted (Fig. 3-1B). Based on this figure, the reaction was 
essentially complete after ~10 mins. 
Similar reaction behaviors were observed during the reactions of wt sw 
Mb with 3-methylphenylhydrazine (Fig. 3-1C-D) and 4-chlorophenylhydrazine 
(Fig. 3-1E-F). The generally accepted chemical equation for the reaction is: 
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Fig. 3-1. UV-vis changes during the reactions of wt sw Mb with phenylhydrazine (A-B), 
3-methylphenylhydrazine (C-D), and 4-chlorophenylhydrazine (E-F). Conditions: 0.1 M 
phosphate buffer, pH 7.4, [protein] = 6 µM, final [reagent] = 1 mM. 
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3.3.2.2 The UV-vis characterization of sw Mb H64A-aryls 
The reactions of ferric sw Mb H64A and the arylhydrazines resulted in 
the decrease of the initial absorbances at 408 nm and 505 nm and the 
appearance of new bands at 436 nm and 544 nm, with an apparent isosbestic 
point at 479 nm (Fig. 3-2A, C, E). The reactions quickly reached completion 
within 1.5 mins (Fig. 3-2B, D, F). 
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Fig. 3-2. UV-vis changes during the reactions of sw Mb H64A with phenylhydrazine (A-
B), 3-methylphenylhydrazine (C-D), and 4-chlorophenylhydrazine (E-F). Conditions: 0.1 
M phosphate buffer, pH 7.4 [protein] = 2 µM, final [reagent] = 1 mM. 
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3.3.2.3 The UV-vis characterization of sw Mb H64Q-aryls 
The reaction completion times of sw Mb H64Q with the arylhydrazines 
are somewhat similar to those of the wt sw Mb reactions (Fig. 3-3). The 
reactions of H64Q with arylhydrazines in solution were essentially complete 
within 7 mins, slower than H64A but slightly faster than wt (Fig. 3-3B, D, F). 
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Fig. 3-3. UV-vis changes during the reactions of sw Mb H64Q with phenylhydrazine (A-
B), 3-methylphenylhydrazine (C-D), and 4-chlorophenylhydrazine (E-F). Conditions: 0.1 
M phosphate buffer, pH 7.4 [protein] = 3 µM, final [reagent] = 1 mM. 
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3.3.2.4 The UV-vis characterization of sw Mb V68A/I107Y-aryls 
The reactions of the Mb double mutant V68A/I107Y with arylhydrazines 
took much longer to obtain the product complexes. As seen in Fig. 3-4A, after an 
overnight reaction with phenylhydrazine, the 407 nm Soret band slowly and only 
partially switched from 407 nm to 430 nm. The reaction stabilized after ~80 
mins (Fig. 3-4B). The reactions with the substituted phenylhydrazine needed to 
proceed for at least 24 hours to partially form complexes as compared to the 
reaction between V68A/I107Y and phenylhydrazine (Fig. 3-4C, E). The 
decreases of the Soret bands at 407 nm for these reactions are plotted as 
shown in Fig. 3-4B, D, F. 
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Fig. 3-4. UV-vis changes during the reactions of sw Mb V68A/I107Y with 
phenylhydrazine (A-B), 3-methylphenylhydrazine (C-D), and 4-chlorophenylhydrazine 
(E-F). Conditions: 0.1 M phosphate buffer, pH 7.4 [protein] = 2 µM, final [reagent] = 1 
mM. 
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3.3.3 The sw Mb-aryls from the crystal soaking method with 
arylhydrazines 
Appropriately sized metMb (wt and mutants) crystals were selected and 
soaked with one of the three arylhydrazine solutions (phenylhydrazine or one of 
the two derivatives). I observed that cracking of the crystals increased the 
longer they were soaked with the organic precursors. Small crystals without any 
visible cracks were separated and selected. An important factor was thus the 
soaking time. If the soaking time was short, the reaction did not go to 
completion, and the final electron density maps in the X-ray structures were 
“messy”. Alternatively, if the soaking time was longer (“too long”), the diffraction 
data was poor; likely due to crystal damage resulting from additional 
introduction of the large organic reagent into other pockets or interfaces of the 
crystal, reducing diffraction quality. Consequently It was important to harvest 
the crystal products at “the correct times” to ensure good X-ray diffraction data 
(see Table 3-2). In order to get good X-ray diffraction, the crystals needed to be 
large enough to diffract at a high resolution, and needed to withstand longer 
periods of time in arylhydrazine solutions. Each protein derivative was different. 
In the cases where the soaking time was longer than three days, the crystals 
were frequently washed with fresh arylhydrazine solutions to introduce fresh 
reagent to achieve complete reaction and to help remove any organic 
byproducts. I found that these are all very important factors in obtaining a good 
crystal structure of the Mb-aryl derivatives, and may explain why there aren’t 
many of these such crystal structures reported in the literature [30, 31]. I note 
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that for each Mb-aryl structure reported in this chapter, I had to optimize the 
reaction conditions using >40 different trials. 
 
Table 3-2. Soaking time (days) of different crystals with phenylhydrazine and 
derivatives 
 Phenylhydrazine 3-methylphenylhydrazine 4-chlorophenylhydrazine 
wt 3 - - 
H64A 2 2 14 
H64Q (P21) 3 2 3 
H64Q (P6) 10 11 - 
V68A/I107Y 1 2 - 
The dash lines indicate structures not obtained. 
 
The pH values of each of the reaction solutions were the same as those 
used to crystallize their metMb precursor crystals. For example, the H64Q 
crystals with the P21 space group (obtained at pH 7.4) were soaked with the 
reaction solutions at pH 7.4. However, reactions of the H64Q crystals (P6 space 
group) obtained at pH 9.0 were performed at this pH.  
 
3.3.4 Crystallographic results of sw Mb-aryls 
The X-ray diffraction data collection, data processing, and refinement 
statistics of 11 complex structures obtained are presented in (Table 3-3). Each 
of the complexes will be described in detail in the following sections. 
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3.3.4.1 The structural characterization of wt sw Mb-phenyl derivative 
The identity of the wt sw Mb-phenyl complex was confirmed by X-ray 
crystallography data at 1.87 Å resolution. To obtain the product, thin needle-like 
crystals of wt sw Mb were soaked with phenylhydrazine solution. As seen in 
Fig. 3-5A and Fig. 3-5B, the phenylhydrazine reagent has lost its “hydrazine” 
functional group, leaving the phenyl group to coordinate with the Fe center of 
heme in the distal pocket to form the Fe-carbon organometallic bond. The 
distance between Fe and the phenyl group (Fe-C bond) is 1.9 Å. On the 
opposite side of the Fe-C bond, the distance between the Fe and the proximal 
His93 (Fe-N) is 2.3 Å.  
 
   
Fig. 3-5. Active site structures of the wt sw Mb-phenyl complex. A) the 2Fo-Fc electron 
density map of the heme pocket in wt sw Mb-phenyl (contoured at 1 σ); B) the Fo-Fc 
omit electron density map and final model of an expanded heme site showing the new 
electron density of phenyl group (contoured at 3 σ). 
 
In order to more clearly detail the active-site structures, the axial ligand 
tilts were defined as follows. “α” and “γ” define the angles between the normal 
of the heme 4N-plane and the Fe-Cphenyl or Fe-NHis93 axis. “β” and ”θ” indicate 
how far the phenyl plane and the imidazole plane of His93 tilt from the Fe-Cphenyl 
B A 
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or Fe-NHis93 axis. “ϕ” stands for the angle between the porphyrin (por)N22-Fe-
N24(por) and the imidazole plane of His93 (or ∠Np-Fe-Nhis-Chis). “ω” represents 
the dihedral angle between the trans phenyl and imidazole planes.  
 
In the wt sw Mb-Ph structure, the (por)N22-Fe-N24(por) diagonal is 
essentially along the plane of the proximal His93 imidazole (ϕ=0.8º ). The 
phenyl plane makes a 35º angle with the trans imidazole plane (Fig. 3-6A). Note 
that the phenyl group is tilted ~6º from the normal to the heme 4N-plane (Fig. 
3-6B). Structural details for this complex and the other derivatives are listed in 
Table 3-4. 
The phenyl group was modeled in the distal pocket at 100% occupancy. 
No hydrogen bonding interactions around the ligand were found. 
 
 
Fig. 3-6. Top (A) and side view (B) of the heme site in wt sw Mb-phenyl.  
B A 
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3.3.4.2 The structural characterization of sw Mb H64A-aryl derivatives 
In order to obtain structural information of the product complexes, 
hexagonal prism-shaped crystals were soaked with the arylhydrazines: 
phenylhydrazine, 3-methylphenylhydrazine, and 4-chlorophenylhydrazine. All 
three crystal structures were obtained after numerous (>40 each) trials: H64A-
phenyl, H64A-tolyl, and H64A-cholophenyl (Fig. 3-7). The crystal structures of 
the complexes are shown in Fig. 3-7, and the selected structural data including 
axial ligand tilts are shown in Table 3-4. Similar to that seen in the wt sw Mb-
phenyl structure, the reaction of phenylhydrazine with ferric sw Mb H64A 
caused the removal of the hydrazine functional group, leaving the phenyl group 
to attach to Fe in the heme pocket (Fig. 3-7A, D). The substitution of the H64 by 
Ala did not alter the identity of the Fe-Ph reaction product. 3-
methylphenylhydrazine and 4-chlorophenylhydrazine reacted with H64A 
similarly (Fig. 3-7B, C, E, F). These two reactions also resulted in the cleavage 
of the hydrazine groups.  
The methyl moiety of the tolyl group in the H64A-tolyl structure is 
oriented towards the hydrophobic interior of the protein. The chloride atom of 
the chlorophenyl group in the H64A-chlorophenyl structure still points up in this 
4-position, which is almost perpendicular to the heme plane. The arrangement 
of the tolyl and cholophenyl groups in our structures confirms that it is the 
carbon atom which was previously bound to the hydrazine functional group 
coordinates with Fe to form the Fe-C bond. No hydrogen bonds around the aryl 
ligands in these three complexes were found. 
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It is interesting to point out that H64A-chlorophenyl has relatively bigger 
α and β angles due to the “distorted” orientation of the chlorophenyl ligand in 
the pocket (see Discussion section).  
Two of the structures, namely H64A-phenyl and H64A-tolyl, were 
obtained after two-days of soaking.  The ligands in these two structures were 
modeled very well with full occupancy (Fig. 3-7A, B, D, E).  Some issues were 
encountered, however, when pursuing the structure of the sw Mb H64A-
chlorophenyl complex. Many of the “successful” crystal structures obtained 
during the soaking trials had the chlorophenyl ligands sitting in the pocket 
nicely. However, if the ligand soaking time was insufficient, then the resulting 
chlorophenyl ligand displayed disconnection in the election density between the 
chloride atom and the phenyl group. The final structure with 80% occupancy of 
the chlorophenyl ligand was obtained after soaking for 14 days,  making sure to 
expose the reaction crystals to the fresh 4-chlorophenylhydrazine solution every 
2-3 days. 
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Fig. 3-7. Active site structures of the sw Mb H64A-aryl complexes. A-C) the 2Fo-Fc 
electron density map of the heme pocket in sw Mb H64A-aryls (contoured at 1 σ); D-F) 
the Fo-Fc omit electron density map and final model of an expanded heme site showing 
the new electron density of phenyl group (contoured at 3, 2.5, and 2.5 σ, respectively). 
 
 
 
 
 
 
 
 
 
B A C 
E D F 
H64A-phenyl H64A-tolyl H64A-chlorophenyl 
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3.3.4.3 The structural characterization of sw Mb H64Q-aryl derivatives 
As noted earlier, ferric sw Mb H64Q can be crystallized either at pH 7.4 
or pH 9.0 (2.56-3.2 M of AS, 100 mM Tris•HCl, 1mM EDTA) with two different 
space groups, P21 (relatively longer hexagonal prisms) or P6 (the hexagonal 
prism) respectively. Three crystalline derivatives were obtained from P21 space 
group (H64Q-phenyl (P21), -tolyl (P21) and -chlorophenyl (P21)) and two 
complexes from the P6 space group (H64Q-phenyl (P6), -tolyl (P6)). I found 
that the crystals belonging to the P6 space group were relatively more difficult 
to react with arylhydrazines, and needed longer soaking times to generate the 
product complexes.  
sw Mb H64Q-aryl derivatives in the P21 space group 
With a mutation from His to Glu at the 64th residue position, the products 
that result from the reaction between ferric H64Q and the three arylhydrazines 
(phenylhydrazine, 3-methylphenylhydrazine, and 4-chlorophenylhydrazine) 
contain similar Fe-aryl linkages as observed with the wt and H64A mutant (Fig. 
3-8). The three resulting complexes are H64Q-phenyl (P21), H64Q-tolyl (P21) 
and H64Q-chlorophenyl (P21), and the carbon initially connected with the 
hydrazine groups in the arylhydrazines remains the carbon that is coordinated 
with Fe in the Mb-aryl products. The three distal pockets from the complexes 
show no hydrogen bonds around the ligands. The ligands in the three complex 
structures were modeled with full occupancy (Fig. 3-8).   
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Fig. 3-8. Active site structures of the sw Mb H64Q-aryl complexes in P21 space group. 
A-C) the 2Fo-Fc electron density map of the heme pocket in sw Mb H64Q-aryls 
(contoured at 1 σ); D-F) the Fo-Fc omit electron density map and final model of an 
expanded heme site showing the new electron density of phenyl group (contoured at 3 
σ). 
 
sw Mb H64Q-aryl derivatives in the P6 space group 
The active site structures of the H64Q Mb products in the P6 space 
group are similar to those in the P21 space group (Fig. 3-9). The reactions 
between the Mb H64Q met crystals and the arylhydrazines took longer than 
most of the other reactions. Two products were obtained, H64Q-phenyl (P6) 
and H64Q-tolyl (P6), after soaking the metMb crystals with the arylhydrazine 
reagents for 10 days and 11 days respectively (Table 3-2). Even after this 
extended soaking time, the phenyl and tolyl groups still could not be modeled 
B A C 
E D F 
H64Q-phenyl (P21) H64Q-tolyl (P21) H64Q-chlorophenyl (P21) 
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with full occupancy, but were modeled with 80% and 60% occupancies, 
respectively (Fig. 3-9A-B).  
 
 
 
Fig. 3-9. Active site structures of the sw Mb H64Q-aryl complex in the P6 space group. 
A-B) the 2Fo-Fc electron density map of the heme pocket in sw Mb H64Q-aryl 
(contoured at 1 and 0.8 σ respectively); C-D) the Fo-Fc omit electron density map and 
final model of an expanded heme site showing the new electron density of phenyl 
group (contoured at 2.6 and 3 σ respectively). 
 
Attempts to model the Gln64 residue in only one orientation yielded 
positive/negative density in the Fo-Fc map. In the H64Q-phenyl (P6) structure, 
Gln64 was modeled with two alternative conformations (20% and 80% 
occupancy). The Gln64 sidechain with 20% occupancy superimposed nicely 
with Gln64 in the met form of H64Q (Fig. 3-15D). Gln64 in H64Q-tolyl (P6) was 
modeled in two alternative conformations as well, but with 50% occupancy 
each.  
H64Q-phenyl (P6) H64Q-tolyl (P6) 
B A 
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3.3.4.4 The structural characterization of sw Mb V68A/I107Y-aryl 
derivatives 
To obtain the X-ray crystal structures of the products, the thin crystals of 
V68A/I107Y were soaked with arylhydrazine solutions. I observed that the 
crystals could only withstand up to two days in the arylhydrazine solutions 
before the resulting crystals would no longer diffract. Eventually, two product 
structures were obtained, V68A/I107Y-phenyl and V68A/I107Y-tolyl (Fig. 3-10). 
The phenyl and tolyl groups were modeled at full occupancy. The electron 
density around the phenyl and tolyl groups was not as prominent, so both of the 
Fo-Fc omit maps were contoured at 2.5 σ (Fig. 3-10C and D). 
In the case of the V68A/I107Y-tolyl structure, and as a result of the steric 
effect from Tyr107, the orientation of the tolyl group points to the hydrophilic 
solvent exterior rather than the hydrophobic interior (see Discussion section).  
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Fig. 3-10. Active site structures of the sw Mb V68A/I107Y-aryl complexes. A-B) the 
2Fo-Fc electron density map of the heme pocket in sw Mb V68A/I107Y-aryls (contoured 
at 1 σ); C-D) the Fo-Fc omit electron density map and final model of an expanded heme 
site showing the new electron density of phenyl group (contoured at 2.5 σ). 
 
 
 
 
 
 
 
V68A/I107Y-phenyl V68A/I107Y-tolyl 
B A 
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3.4 Discussion 
3.4.1 Formation of sw Mb-aryl complexes as monitored by UV-vis 
spectroscopy 
The appearance of a new band at ~433 nm in the UV-vis spectra during 
the reactions of sw Mb and arylhydrazines matches that previously reported for 
the MbFe(III)-phenyl complex [28, 29]. We do notice that the absorbance 
intensity at 430 nm for the Mb-aryl derivatives is much lower than the 
absorbance intensity of the starting met form at ~408 nm. The reduction in 
intensity is probably caused by likely change in extinction coefficient of the 
products and the destruction of the heme due to the formation of free radicals 
and H2O2 from these reactions. This reduction in absorbance intensity was also 
observed in the reactions of another heme containing protein, prostaglandin H 
synthase (PGHS), with hydrazines [32].  
I found that after completion of the reaction, the Mb-aryl products are 
stable in air for at least four days. For example, as shown in Fig. 3-11A, the wt-
phenyl product in solution still retained its λmax at 433 nm after four days. This 
result also matches the UV-vis spectral data using dissolved crystals of sw Mb 
wt-phenyl (Fig. 3-11B). The crystals of wt Mb-phenyl complex (confirmed by X-
ray crystallography) were left in reaction solution for 5 days, and then the 
product crystals were dissolved in phosphate buffer to obtain the UV-vis 
spectrum. A clear absorbance at 434 nm was still observed (Fig. 3-11). 
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Fig. 3-11. Stability of sw Mb wt-phenyl from the reaction solution (A) and using 
dissolved crystals of the product (B). The band at ~433 nm does not change in intensity 
even after 4 days. 
 
3.4.2 Heme is the determining factor in the reaction of sw Mb with 
arylhydrazines 
Phenylhydrazine and its derivatives react with wt Mb and the three 
mutants to form similar products in these three proteins. The reactions cause 
the cleavage of hydrazine moieties, and the subsequent coordination between 
the heme Fe and the carbon atom that was originally connected with the 
hydrazine moiety (middle of Fig. 3-12). Consequently, the reactions of the 
hydrazine compounds with sw Mb result in the formation of the sw Mb-phenyl, 
sw Mb-tolyl and sw Mb-chlorophenyl complexes. The identities of the Fe-aryl 
reaction products did not change with mutation of the residues in the distal 
pocket and the different crystal packing forms. This indicates that the heme 
(and not the distal pocket residues) is most likely the determining factor in these 
reactions. 
B A 
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It has been reported that isolation of the heme-phenyl moiety from the 
protein, using strong acid and air, caused the formation of four N-
phenylprotoporphyrin IX regioisomers characterized by an identical Soret band 
at 412 nm in CHCl3 [28]. The zinc complexed N-phenylprotoporphyrin IX 
isomers in CHCl3 displayed similar spectra with non-identical Soret bands: 440 
nm for isomer I and II; 442 nm for isomer III; 444 nm for isomer IV [28, 33]. 
 
N
N
N
N
FeIII
O2
NH
H2N
N
N
N
N
FeIII
N
N
N
N
FeIII
H+/O2
H+ + N2 + ~430 nm N-phenylprotoporphyrin IX:
412 nm in CHCl3
Zinc N-phenylprotoporphyrin IX:
440-444nm in CHCl3  
Fig. 3-12. Proposed reaction mechanism of sw Mb and arylhydrazines [28, 33-35]. 
Only the heme site is shown. 
 
3.4.3 Conformational changes occur for residues in the distal pocket 
The exact identity of the residues in the heme distal pocket does not 
appear to alter the product formation, but they can alter other factors involved in 
these reactions such as the reaction rate. As compared to the respective met 
precursors, the structures of the Mb-aryl products have a similar overall 
structure with RMSD of ~0.2 Å, and the only significant changes occured in the 
active site. In order to accommodate the aryl ligands bound with heme iron, 
some distal pocket residues need to change their conformations considerably. 
This was observed through comparisons between the sw Mb met form 
structures [36, 37] (some of them were reproduced in this work and used as 
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controls) and the product structures obtained after the ligands were introduced 
(Fig. 3-13).  
 
 
 
 
Fig. 3-13. Comparisons of the heme pockets from each sw Mb derivatives. A) 
alignment of wt-H2O (met form) and wt-phenyl; B) alignment of H64A-H2O, H64A-
phenyl, H64A-tolyl and H64A-chlorophenyl; C) alignment of H64Q-H2O, H64Q-phenyl, 
H64Q-tolyl, and H64Q-chlorophenyl in P21 space group; D) alignment of H64Q-H2O, 
H64Q-phenyl, and H64Q-tolyl in P6 space group; E) alignment of V68A/I107Y-H2O, 
V68A/I107Y-phenyl, and V68A/I107Y-tolyl. Note: green represents the met forms, 
magenta for the complexes with phenyl, cyan for the ones with tolyl, and yellow for the 
ones with chlorophenyl.   
 
The residue His64 in wt (Fig. 3-13A) and V68A/I107Y (Fig. 3-13E), and 
the Gln64 in H64Q (Fig. 3-13C, D) fully or partially alter their inward orientations 
(initially pointing towards the heme in the distal pocket) to an orientation 
pointing to the protein exterior with flip angles ~90º. Accordingly, accompanying 
B A 
D C E 
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the changes in His64 (Fig. 3-13A, E) or Gln64 (Fig. 3-13C, D), the Arg45 
residues also changed from “inward” to “outward” orientations in several of 
structures. The “outward” orientations of H64/Q64 and Arg45 appear to create 
an open entry to accept the ligands (Fig. 3-13A, C-E). For example, the active-
site volumes of wt-H2O and wt-phenyl, calculated by the program Hollow, 
illustrate the contour of the pores (Fig. 3-14) [38]. The interior surface around 
the distal pocket was computed using dummy atoms as probes with a radius of 
1.4 Å (close to the size of a water molecule).  Before any ligands are introduced 
to wt-H2O, the cavity (purple) is essentially a closed environment (Fig. 3-14A). 
After the phenyl group coordinates to Fe in the pocket, and due to the 
orientation changes of two residues, His64 and Arg45, the cavity opens up (its 
gate) to accommodate the phenyl group shown in black (inside of the cavity, 
Fig. 3-14B). 
 
   
Fig. 3-14. The active-site cavities in wt-H2O and wt-phenyl. A) a close “mouth” in wt-
H2O, B) an open “mouth” in wt-phenyl. 
B A 
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As described earlier, in H64Q-phenyl (P6) and H64Q-tolyl (P6), the 
phenyl and tolyl groups were modeled at 80% and 60% occupancies 
respectively. The relatively lower electron densities around the ligands (see Fig. 
3-9) suggest incomplete reactions. The comparison of the H64Q product 
structure in the P6 space group provides structural evidence for the incomplete 
reactions (Fig. 3-13D). The electron densities of the Arg45 sidechains in all the 
H64Q structures (P6) are not strong enough to determine the precise position of 
this residue. However, the best modeled positions suggest that Arg45 prefers 
the inward orientation which does not normally favor ligand binding. This helps 
explain why the arylhydrazines did not react with these heme proteins to 
completion. 
In most cases, Val68 flipped its orientation from horizontal to vertical 
(Fig. 3-15), except in the H64A-chlorophenyl structure. Since the chlorophenyl 
group is further away from Val68 and tilted toward Phe43 to form a 73o angle 
with the heme plane (Fig. 3-15B and Fig. 3-13B), it is perhaps not necessary for 
Val68 to flip. The alternative conformations were modeled for the Val68 
sidechains in the H64Q (P6) structures, e.g. H64Q-phenyl (P6) and H64Q-tolyl 
(P6). The Val68 in these two structures seem to prefer the vertical orientation. 
Since the reactions were not fully complete, the horizontal conformations are 
not completely switched to the vertical positions. This is perhaps also the 
reason why Gln64 in these two complexes was best modeled in two 
conformations (Fig. 3-15D). 
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The isopropyl of the Leu61 residue at the “top position” in the distal 
pocket tends to be “horizontal” when ligands bind with iron. Thus, the isopropyl 
of Leu61 is “vertical” in sw Mb-H2O, but switches to the “horizontal” orientation 
after a ligand enters into the pocket. This is seen in the wt-phenyl (Fig. 3-15A), 
V68A/I107Y-phenyl (Fig. 3-15E) and V68A/I107Y-tolyl (Fig. 3-15E) structures. 
Alternatively if the isopropyl of Leu61 in sw Mb-H2O is already the horizontal 
conformation, it will retain this position after the ligand enters into the pocket. 
This is exactly what is seen in the H64A-phenyl (Fig. 3-15B), H64A-tolyl (Fig. 
3-15B), the three H64Q-aryl structures in the P21 space group (Fig. 3-15C), 
H64Q-phenyl (P6) (Fig. 3-15D), H64Q–tolyl (P6) (Fig. 3-15D), and H64A-
chlorophenyl (Fig. 3-15B; the latter just partially changes to the vertical 
conformation, and gives two alternative conformations in the isopropyl of Leu61 
due to the steric effect of chloride).  
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Fig. 3-15. Closer views of the active site environments in the sw Mb precusors and 
derivatives (zoomed-in from Fig. 3-13). A) wt; B) H64A; C) H64Q (P21); D) H64Q (P6); 
E) V68A/I107Y. Note: green stands for the met forms, magenta for the complexes with 
phenyl, cyan for the ones with tolyl, and yellow for the ones with chlorophenyl.   
 
The isopropyl group of Leu29 is in the vertical conformation for most of 
the complexes (wt, H64A and V68A/I107Y); however, the Leu29 in H64Q-tolyl 
(P21) and H64Q-tolyl (P6) has two conformations, vertical and horizontal, 
modeled at 50% occupancy each (Fig. 3-15C, D). This may be due to the steric 
effect from the methyl group of the tolyl moiety. 
B A 
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It is interesting to point out that among the above residues that showed 
conformational changes of the sidechains (except Arg45 which is in the CD loop 
of Mb) Leu61, Val68 and His64/Gln64 are all located in the E helix which shows 
a more important role in this work than previously thought in the interactions 
with similar ligands. 
Some uncommon conformational changes were also observed in this 
work. A significant movement of the CD loop was observed in the H64A-
chlorophenyl structure. The entire CD loop moves down and outward when 
compared with the other structures (Fig. 3-16). Such a conformational change 
was not readily observed in the other structures. 
 
 
Fig. 3-16. Alignment of the four H64A structures: H64A-H2O (green), H64A-phenyl 
(magenta), H64A-tolyl (cyan) and H64A-chlorophenyl (yellow). The arrow indicates the 
“downward” movement of the CD loop in H64A-chlorophenyl. 
 
I also observed that the phenyl group of the Phe46 residue in the H64A-
chlorophenyl product is rotated by ~45o relative to its position in the H64A-H2O, 
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and switched its original inward orientation (pointing towards the heme in the 
distal pocket) to an orientation towards the protein exterior (Fig. 3-13B). The 
position change of Phe46 is interesting because it was initially thought to be 
relatively stable, according to our structural data from the sw Mb complex with 
NOx ligands (see Chapter 2). In the sw Mb-NOx structures in Chapter 2, the 
conformational change of Phe46 is not due to the binding of the NOx species, 
and is only related to the mutations of the other residues in the distal pocket. 
The example of H64A-chlorophenyl here showed us that ligands other than 
NOx species can induce changes in Phe46 orientation (Fig. 3-13B). The 
sidechain of Ile142 in V68A/I107Y-phenyl and V68A/I107Y-tolyl also 
unexpectedly changed their conformations, unlike that observed in V68A/I107Y-
H2O. Specifically, in the V68A/I107Y-tolyl structure, the methyl group of Ile142 
switched its orientation to the reverse orientation (Fig. 3-13E).  
3.4.4 A “down shift” was observed for the heme and the proximal residues 
The heme and the proximal residues in most of the structures all 
experienced a small “down shift” of their positions, when compared with their 
positions in the sw Mb-H2O precursors. For example, if we zoom into the 
proximal pocket in Fig. 3-13A as redisplayed in Fig. 3-17, the proximal residues 
of wt-phenyl in this figure move down by ~0.5 Å as compared with the wt-H2O. 
Most of these residues are located in the F helix in Mb. 
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Fig. 3-17. Comparison of proximal pockets of wt-H2O (green) and wt-phenyl (magenta). 
The arrow shows the down shift.  
 
An exception to this is the H64A-chlorophenyl derivative. As mentioned 
earlier, the chlorophenyl ligand in H64A-chlorophenyl tilts away from the normal 
to the heme plane and forms an 80o angle with the heme plane, which in turn 
pushes one side of the heme down (right side of Fig. 3-18) and the other side 
up (left side of Fig. 3-18). Consequently, half of the proximal residues do 
experience a down shift (right side of Fig. 3-18) and half of them experience a 
slight upshift. 
 
Fig. 3-18. Comparison of proximal pockets of H64A-H2O (green) and H64A-
chlorophenyl (yellow).  
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3.4.5 Crystal packing mode can affect the active site conformation 
Crystals of sw Mb can be grown either in P21 or P6 space groups. I find 
that the crystal packing mode can also affect the active site conformation in the 
structures.  The differences are shown in Fig. 3-19.  
 
 
 
Fig. 3-19. Superimposition of the sw Mb derivatives. A) five structures sw Mb-H2O; B) 
five structures sw Mb-phenyl; C) four structures sw Mb-tolyl; D) two structures of sw 
Mb-chlorophenyl. Each sw Mb structure is labeled by a different color; green (wt (P21)), 
cyan (H64A (P6)), magenta (H64Q (P21)), yellow (H64Q (P6)), and salmon 
(V68A/I107Y (P21)). 
B A 
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The proteins with the same ligands were aligned using their Cα chains. 
Differences among each set of the structural alignments with the same ligands 
appear to be mostly caused by the conformational changes associated with the 
space groups (P21/P6) and not by the mutations. Previous results showed that 
the structures of wt sw Mb in both P21 and P6 space groups are essentially 
identical, and the major differences were observed only in the sidechains on the 
protein surface [39, 40]. However, our results show differences not only in the 
sidechains of the surface residues, but also the interior residues. Selected 
residues are shown in Fig. 3-19. The residues from H64A P6 (cyan) and H64Q 
P6 (yellow) are all grouped together and slightly shift from P21 space group 
residues (especially the residues shown in Fig. 3-19). An enlarged proximal 
pocket of Fig. 3-19B for the sw Mb-Ph complex is shown below (Fig. 3-20). All 
residues in this figure are grouped into two different conformations by colors: 
the cyan and yellow represent the structures in the P6 space group; the other 
three represent those in the P21 space group.  
The alignment of complexes with chlorophenyl in Fig. 3-19D uses only 
two structures (H64A-chlorophenyl and H64Q-chlorophenyl (P21)), but the 
differences are similar to those shown in Fig. 3-19A-C. 
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Fig. 3-20. Closer views of the proximal pocket in the sw Mb-Ph derivatives (Zoomed-in 
from Fig. 3-15B). Each of sw Mb is labeled with different color; green (wt (P21)), cyan 
(H64A (P6)), magenta (H64Q (P21)), yellow (H64Q (P6)), and salmon (V68A/I107Y 
(P21)). 
 
The difference between the aqua-met form and complexes discussed 
above is the function of the two different space groups. For example, after 
phenyl coordinates to Fe, the isopropyl group of Leu61 either (i) switches from a 
vertical (Fig. 3-21A) to a horizontal position (Fig. 3-21B) as seen in wt (green) 
and V68A/I107Y (salmon) or (ii) keeps its horizontal position in H64A (P6) 
(cyan), H64Q (P21) (magenta) and H64Q (P6) (yellow). With this ligand binding, 
the Leu61 residues in two different groups tend to group together and slightly 
shift towards each other within two groups no matter how the sidechains 
change (see the Cα and isopropyl group of Leu61 in Fig. 3-21).  This was also 
observed with other residues such as His/Gln 64 in Fig. 3-21. 
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Fig. 3-21. Changes resulting from ligand binding as a function of the two different 
space groups. A) five structures of sw Mb-H2O; B) five structures of sw Mb-phenyl. 
Each of sw Mb is labeled by a different color; green (wt (P21)), cyan (H64A (P6)), 
magenta (H64Q (P21)), yellow (H64Q (P6)), and salmon (V68A/I107Y (P21)). 
 
As noted earlier, H64Q can crystallize at pH 7.4 or pH 9 in the P21 and 
P6 space groups, respectively. This mutant protein thus provided a very nice 
control when performing the soaking experiments. The crystals in the P21 space 
group react much faster than the crystals in the P6 space group. The H64Q-
phenyl and H64-tolyl structures in the P6 space group still showed the relative 
low occupancy of the ligands (80% and 60% respectively) and the alternative 
conformation for both Val68 and Gln64, although the crystals were soaked for 
more than 10 days, which suggests incomplete reactions. I hypothesized that 
the crystal packing mode can thus also affect the extent of the reaction. In other 
words, a crystal in the P21 space group might be more accessible to the ligands 
than the one in P6 according to the result using the H64Q mutant. I checked the 
B A 
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crystal packing of those two space groups of H64Q in Pymol, by assembling all 
symmetry mates within 50 Å of a reference point (Fig. 3-22). 
 
Fig. 3-22. Crystal packing of H64Q-H2O in the two different space groups P21 (A) and 
P6 (B). The molecules labeled by magenta are heme molecules. The solvent channels 
around heme were zoomed in on the right panels. The red spots in the two figures are 
water molecules.  
 
There are 42 monomers in the P21 space group and 52 in the P6 space 
group within a 50 Å radius (Fig. 3-22). We do notice that hemes (labeled by 
B 
A 
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magenta) in P21 and P6 are exposed to large channels which are accessible to 
solvents (right panels in Fig. 3-22). The interior solvent volume of the two 
assemblies generated by Pymol above was calculated using the 3V server [41]. 
Two probes with radii of 6 Å and 1.5 Å (the approximate size of a water 
molecule) were rolled through the surface of two assemblies to obtain the 
solvent channel in Fig. 3-23 with volumes of 260245 Å3 for P21, and 248317 Å
3 
for P6. It thus seems that the P21 form is slightly more accessible to solvent 
than P6.  
 
Fig. 3-23. The solvent channels of H64Q in the two different space group P21 (A) and 
P6 (B). These two assemblies were generated by Pymol and saved as the related 
coordinate files which were input into 3V server. The final images with interior channels 
were displayed by Chimera. 
 
However, it is also evident from Fig. 3-23 that solvent and reagent can 
have better access to the interior solvent channel in P6 space group. There are 
also the experimental data to support this point. I note that the H64A derivatives 
are in the P6 space group, but have fast and stable reactions with 
arylhydrazines to give the H64A-phenyl and H64A-tolyl products. In addition, 
A B 
128 
the wt and V68A/I107Y crystals with P21 space group have slow reaction times. 
There is not enough evidence at this time to show conclusively whether the 
crystal packing mode affects the outcome of the reaction. The comparison of sw 
Mb-H2O which shows us another clue is shown in Fig. 3-24 (enlarged picture of 
Fig. 3-19A). 
 
Fig. 3-24. Comparison of the sw Mb-H2O structures. Each sw Mb is labeled by a 
different color, green (wt), cyan (H64A), magenta (H64Q (P21)), yellow (H64Q (P6)), 
and salmon (V68A/I107Y). 
 
The Arg45 in cyan (H64A-H2O) and magenta (H64Q-H2O (P21)) are 
oriented towards the outside of the heme pocket. The other three Arg45s in wt-
H2O (green), H64Q-H2O P6 (yellow), and V68A/I107Y-H2O (salmon) point to 
the protein interior which is thought to block ligand entrance (Fig. 3-24) 
according to the calculated results using Hollow (Fig. 3-24). During the soaking 
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experiments, only H64A and H64Q in P21 provided products of all three 
complexes with the best visualization of Fo-Fc maps. In other words, if the 
starting protein, met form (Mb-H2O), has an outward orientation of Arg45, it 
might be easier to accommodate the ligands in the pocket.  
 
3.4.6 The Tyr107 in V68A/I107T may direct the orientation of the methyl 
group in the Mb-tolyl derivatives 
The methyl substituent of the tolyl group in the V68A/I107Y derivative 
(P21), with His64 in the distal pocket, points to the outside of the distal pocket, 
but the other three tolyl derivatives with the mutations at position 64 show that 
this methyl substituent points to the inside (Fig. 3-19C). As noted in Chapter 2, 
His64 plays a central role in NOx ligand orientations. However, in the 
V68A/I107Y, it appears that it is the bulky and hydrophilic Tyr sidechain that 
causes the methyl position to be located toward the protein exterior. 
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Chapter 4 Crystal structure and a preliminary functional assay 
of a non-metal FMN-binding nitroreductase from 
Clostridium difficile 
 
4.1 Introduction 
Clostridium difficile is a gram-positive and spore-forming anaerobic 
bacterium that infects colonic epithelial cells and causes life-threatening 
diarrhea and colitis [1]. At least 250,000 infections occur each year with about 
14,000 associated deaths in the U.S. alone [2]. Both the infection rate and 
mortality rate continue to increase. Better detection methods, the frequent use 
of antibiotics and chemotherapeutics, and contaminated hospital environments 
are all believed to contribute to this documented increase [3, 4]. Individuals 
younger than 65 years in age are susceptible to C. difficile infections (CDIs), 
accounting for about 50% of all CDIs, but high mortality (~90%) occurs in 
individuals of age 65 and older [1, 2]. Among all strains of C. difficile, the 
hypervirulent strain R20291 causes more severe diarrhea that correlates with 
higher morbidity, mortality and recurrences. It was conservatively estimated that 
at least $1.1 billion per year is needed to treat CDIs in United States [5]. 
Metronidazole and vancomycin are the commonly used drugs for the 
treatment of C. difficile that reduce morbidity and mortality [6]. Metronidazole 
(MTZ; see below) is a low-cost nitro-containing drug that has high activity in 
vitro, high level of efficacy, and is postulated to have low potential for the 
selection of vancomycin-resistant Enterococcus (VRE) [6-8]. However, recent 
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reports show an increased failure of treatments of CDIs with metronidazole [6, 
9, 10]. A recurrence rate of 15-35% has been reported for both metronidazole 
and vancomycin after initial successful therapy [6, 11, 12]. The resistance and 
reduced susceptibility to metronidazole and vancomycin have been 
documented [13, 14]. 
 
Metronidazole typically functions as a prodrug which interacts with 
nitroreductase proteins in pathogens, and produces toxic metabolites to kill the 
pathogens. Metronidazole resistance has been related to a nitroreductase in 
Bacteroides fragilis [15-17] and Helicobacter pylori [18, 19], but with different 
mechanisms depending on whether the products from the metabolism of 
metronidazole by nitroreductases are toxic or non-toxic. Resistance to 
metronidazole in B. fragilis has been shown to be associated with nim genes 
[15-17]. Nim genes encode the nitroreductases that convert metronidazole to 
non-toxic amine derivatives, thus avoiding the formation of toxic nitroso or 
hydroxylamine derivitatives. These previously silent nim genes may be 
expressed or upregulated in the resistant strain, and thereby reduce nitro-
containing durgs to non-toxic products such as amino derivatives which were 
not found in sensitive strains [15, 16]. In contrast, metronidazole resistance in 
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H. pylori is related to mutations of the rdxA and frxA genes, encoding 
nitroreductases that reduce nitro-containing drugs (e.g., metronidazole) to toxic 
nitroso or hydroxylamine derivatives [18, 19]. The inactivation of mutated rdxA 
and frxA prevented the formation of toxic products and further caused 
metronidazole resistance [19]. Only a few studies on metronidazole resistance 
in C. difficile have been reported. It is interesting to note that a truncated 
mutation in a nitroreductase was found in both a resistant strain and a sensitive 
strain with reduced susceptibility, implicating it in metronidazole resistance in C. 
difficile [20]. 
Nitroreductases are a family of FMN-dependent, NAD(P)H-linked 
proteins that transform nitro-substituted compounds to their corresponding toxic 
nitroso, hydroxylamine or non-toxic amine derivatives. This metabolic feature 
has attracted attention in bioremediation efforts for the cleanup of spent nitro-
containing explosives such as TNT in contaminated soils [21]. Recently, more 
interest has been drawn to clinical biotechnological applications for cancer 
treatments [22, 23]. Based on the responses to oxygen during the reactions, 
nitroreductases are characterized as type I or type II (see the scheme below) 
[24].  
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Nitroreductases are widely distributed in bacteria, and also exist in 
archaea and eukaryotes [24]. They catalyze the reduction of nitrocompounds in 
a ping-pong bi-bi kinetic mechanism and usually behave as homodimers 
varying in size (24-30 kDa) for each subunit [24]. The reactivity of nitro 
substrates with other bacterial nitroreductases is well known. The emergence of 
metronidazole-resistant C. difficile strains has created a critical need for 
understanding nitroreductase interactions with metronidazole. Only three 
nitroreductases from C. difficile have been reported, and these were from the 
less-virulent C. difficile 630 strain. These structures were deposited in the PDB, 
but no manuscripts describing the structures have been published. There is 
currently no structural information of any nitroreductase from the hypervirulent 
C. difficile R20291 strain and no functional assays for the reaction of nitro 
substrates (e.g., metronidazole) with nitroreductases in any C. difficile strain. 
In this work, I determined the X-ray crystal structure of a 26 kDa 
nitroreductase (CDR20291_0684) from the hypervirulent C. difficile R20291 
strain, which represents the first structural determination of a nitroreductase 
from the C. difficile hypervirulent strain. I also investigated the reaction of 
metronidazole with this nitroreductase, which is the first confirmation of the 
reduction of metronidazole by a nitroreductase in C. difficile. This work provides 
a future direction regarding the molecular basis of antibiotic resistance of C. 
difficile to the prodrug metronidazole. 
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4.2 Materials and methods 
4.2.1 Cloning 
A putative nitroreductase gene (CDR20291_0684) was identified from 
the genome sequence of hypervirulent C. difficile by a BLAST search against 
the annotation and conserved domain [25]. The recombinant plasmid 
pNYCOMPSC-0684 with the nitroreductase gene was constructed by our 
collaborators at the Albert Einstein College of Medicine (AECOM), and 
contained a C-terminal His10 tag extension to facilitate its purification. 
4.2.2 Expression and purification of nitroreductase 
The plasmid pNYCOMPSC-0684 was transformed into E. coli BL21 
(DE3) competent cells. The nitroreductase was expressed in the cells with auto-
induction [26]. In brief, cells were grown in ZY auto-inducing medium [26] 
supplemented with kanamycin (50 µg/ml), MgSO4 (1 mM), glycerol (0.5%), 
glucose (0.05%), α-lactose (0.2%), 100 M vitamin B12, and trace metals. 
Autoinduction is performed in an incubator with shaking. The temperature was 
set to 37°C for 5 h then adjusted to 22°C and left to incubate overnight. 
After the cell pellets were harvested by centrifugation, the resulting 
yellow pellets were transferred into an anaerobic COY chamber containing 3% 
H2 (in N2). All purification procedures were performed in the chamber. The 
collected cells were resuspended in the binding buffer (0.1 M sodium 
phosphate, 0.5 M NaCl, 20 mM imidazole, 2 mM β-mercaptoethanol). The 
appropriate amounts of DNase, RNase, and PMSF were added in the solution. 
The sample was sonicated on ice. After centrifugation, the supernatant was 
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loaded onto a Ni affinity column (MCLAB) equilibrated with binding buffer.  The 
column was then washed with the washing buffer (binding buffer but with 50 
mM imidazole). The attached His-tagged protein was eluted from the column 
with the elution buffer (binding buffer with 250 mM or 500 mM imidazole). 
Fractions were collected throughtout the column and the presence of protein 
was verified by SDS-PAGE. 
The eluted protein fractions were pooled and concentrated using an 
Amicon ultra filter with a cutoff of 10 kDa (Millipore). The concentrated sample 
was applied to a gel filtration Superdex 200 increase 10/300GL column set up 
on an AKTA FPLC system (GE Healthcare) equilibrated with gel filtration buffer 
(20 mM Tris, pH 7, 2 mM β-mercaptoethanol). The elution profile of the 
nitroreductase was monitored and recorded at 280 nm by UV light in an AKTA 
FPLC. The molecular mass of nitroreductase was estimated relative to the 
molecular masses of other proteins used as standard proteins; conalbumin (75 
kDa), ovalbumin (44 kDa), carbonic anhydrase (29 kDa), and ribonulease A 
(13.7 kDa). The fractions containing the nitroreductase (by SDS-PAGE) were 
pooled and concentrated to ~5 mg/ml. 
4.2.3 Crystallization of nitroreductase 
Broad screen crystallization trials (MCSG1, MCSG2, CSHT, and Wizard) 
were carried out in the nanoliter scale with a Mosqito robot (TTP Labtech). The 
sitting drop vapor diffusion method was used by mixing 300 nl of protein and 
300 nl of well solutions in MRC 2 subwell plates (Swissci) with 60 µl of well 
solution. After a couple of days, tiny rod shaped yellow crystals with sizes 
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around 20 µm formed in MCSG1 (Microlytic) well C8 (0.2 M ammonium sulfate, 
25 % PEG 4000, 0.1M sodium citrate, pH 5.6). Larger crystals (~140 µm long) 
were obtained after manual optimization in 10% PEG 1500, 0.1 M sodium 
citrate, and pH 5.6. In order to obtain good diffraction data from the crystals, the 
crystals were washed in a cryosolution of the same composition as that used in 
the crystal well solution but with 25% ethylene glycol. 
4.2.4 Data processing, structure solution and refinement 
Selected yellow crystals were sent to the Stanford Synchrotron Radiation 
Laboratory (SSRL) for X-ray data collection at the BL12-2 beam line.  
The diffraction data was processed using HKL3000 [27]. The structure 
factors were calculated using the CCP4 program suite [28].  
The three-dimensional structure of the full-length nitroreductase was 
solved by molecular replacement in PHASER (CCP4) [28, 29] using an 
ensemble of the superimposed models from PDB_3PXV (D. hafniense) and 
PDB_3EK3 (B. fragilis). All refinements were performed by Refmac5 [28, 30]. 
The model was rebuilt by COOT [31]. The MolProbity server was used for 
structure validation [32].  
Ten initial cycles of restrained refinement were run with Refmac, and the 
R factor decreased from 0.40 to 0.33. Ligands (FMN, phosphate ion) and water 
were added to the model based on the Fo-Fc electron density maps in the 
subsequent refinement cycles. An FMN co-factor restraint file was generated 
using ACEDRG [28]. Two FMN co-factors, one glycerol, and one phosphate 
anion were added into the model. 138 water molecules were sequentially added 
140 
by COOT. Two conformations of the sidechains of Asp7 in monomer A and 
Ile154 in monomer B were modeled with 50% occupancy for each 
conformation. Some residues in monomer A (the first 5 residues in N-terminus 
and 18 residues in C-terminus) and monomer B (6 residues in N-terminus and 
16 residues in C-terminus) were omitted because of the lack of clear electron 
density. The final R factor and Rfree are 0.17 and 0.22, respectively. 
4.2.5 Assay of nitroreductase activity 
The protein concentration was calculated using the calculated extinction 
coefficient at 280 nm of 21430 l/cm/mol from ProtParam [33]. The reduction and 
re-oxidation of the nitroreductases were examined under anaerobic conditions. 
All buffers were purged by nitrogen gas for at least 30 min and moved into the 
anaerobic chamber. The titration experiments were carried out in the chamber 
as described previously [34]. A sealable quartz cuvette (Starna cells) with a 
septum was used. In general, ~17 µM of nitroreductase in 3 ml of 20 mM Tris 
pH 7, was reduced by sequentially adding 1 µl of dithionite (11 additions) at ~20 
mM in the same buffer as the protein to obtain the spectrum of reduced form. 
Re-oxidation of nitroreductase was then performed by also sequentially adding 
1 µl of nitro-containing drugs (nitrofurazone or metronidazole; 12 sequential 
additions each) at 1 mM into the reduced protein. After each addition, the 
cuvette was sealed and UV-vis spectra were recorded using a Hewlett Packard 
8453 spectrophotometer. 
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4.3 Results 
4.3.1 Protein characterization 
The nitroreductase (CDR20291_0684) was expressed in good yield (~50 
mg/L) in E. coli. The purified protein showed a deep yellow color as expected 
for an FMN-containing protein. The protein was obtained in high purity (>98%) 
as shown by SDS-PAGE, and the band was located just above the 25 kDa 
marker band, matching the calculated nitroreductase molecular mass of 26 kDa 
(Fig. 4-1A). Information from gel filtration of the protein indicates that it was 
isolated as a dimer; this corresponds well with that previously reported for other 
bacterial nitroreductases [35-39]. Yellow crystals (~20 µm) were obtained from 
an initial MCSG1 screen with larger crystals (~140 µm) obtained after manual 
optimization (Fig. 4-1B). 
 
 
Fig. 4-1. A) nitroreductase characterization by SDS-PAGE analysis of the purified 
nitroreductase after gel filtration: 1 Marker, 2-6 fractions; B) Crystals of the 
nitroreductase. 
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4.3.2 Overall structure of nitroreductase from hypervirulent C. difficile 
R20291 
The three dimensional structure at 2.1 Å resolution was obtained from a 
crystal in the space group P41212 (Table 4-1). The crystal structure revealed 
that the nitroreductase is a homodimer (Fig. 4-2A) with each monomer binding 
one equivalent of FMN. The cloned protein has 231 amino acid residues 
including 10 His residues and 8 extra residues in the C-terminus from the 
plasmid. Based on the electron density map, 208 residues were modeled into 
monomer A excluding 5 residues in the N-terminus and 18 residues in the C- 
terminus due to the lack of electron density. 209 residues were modeled into 
monomer B that lacked clear electron density for 6 residues in N-terminus and 
16 residues in C-terminus.  
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Table 4-1. Data collection and refinement statistics 
Protein No. 
CDR20291_0684 
YP_003217185 
PDB ID 5J62 
Data collectiona  
Space group P 41 21 2 
Wavelength (Å) 0.98 
        Cell dimensions (Å, deg) 
100.32, 100.32, 99.92 
90.00, 90.00, 90.00 
Resolution (Å) 50.00-2.12 
I/σ[I] 17.33 (0.67) 
No. of reflections  
    Observed 530168 
    Unique 55935 (2675) 
Multiplicity 9.5 (3.8) 
Completeness (%) 99.7 (96.7) 
Rmerge
b
 0.071 (0.782) 
  
Refinement statistics  
No. of protein atoms 3274 
R factor (%)
c
 0.17 
Rfree (%)
d  0.22 
RMSD Bond lengths (Å) 0.016 
RMSD Bond angles (°) 1.700 
B Factor 50.32 
Ramachandran plot (%)e  
    Most favored residues 98.8 
    Outliers 0.24 
 
a
 Values in parentheses correspond to the highest resolution shells. 
b
 Rmerge=Σ|I-<I>|/Σ(I), where I is the individual intensity observation and <I> is the mean of all 
measurements of I.  
c
 R=Σ||Fo|-|Fc||/Σ|Fo|, where Fo and Fc are the observed and calculated structural factors, 
respectively.  
d
 Rfree was calculated by using 5% of the randomly selected diffraction data which were 
excluded from the refinement.  
e
 As calculated using MOLPROBITY. 
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The protein adopts a classic nitroreductase α+β fold [34, 40] with the 
FMN cofactors located at the interface of the monomers. Each monomer 
consists of a β-sheet in the central core surrounded by α-helices (Fig. 4-2A, B).           
 
 
Fig. 4-2. Crystal structure of the nitroreductase. A) Overall crystal structure of 
nitroreductase showing the dimeric configuration and FMN-binding sites (stick model in 
magenta); B) Topology of the monomer (using PDBsum).  
 
The five-strand β sheet (β5β1β2β4β3) arrangement is formed from four 
antiparallel β strands (β1β2β4β3) (Fig. 4-2B) complemented by a fifth strand β5 
from the other monomer (Fig. 4-3). Each monomer folded in a similar 
conformation except one segment comprised of α6 and α7 (see the arrows in 
the right panel of Fig. 4-3) which stretched out in monomer A instead of folding 
down and wrapping the α3 in monomer B. The helices of α6 and α7 in monomer 
B are shorter and partially unfold into a disordered structure in order to wrap 
A B 
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around α3. To stabilize the disordered segment, monomer B forms an extra β 
sheet out of the β sheet in the central core (circled area in Fig. 4-3 right).   
 
 
Fig. 4-3. Views of the nitroreductase structure. The structure is shown in two different 
orientations with a 90° rotation around the vertical axis. The yellow represents 
monomer A and the cyan represents monomer B. The motifs of the secondary 
structure in the monomer A are labeled in the structure. Arrows point to the segments 
with different folding in each monomer. The circled area is the extra β sheet in 
monomer B.  
 
We searched for homologs of the nitroreductase (CDR20291_0684) 
using the amino acid sequence (NCBI BLAST). The resulting twelve potential 
homologs are listed in Fig. 4-4, and all showed <30% sequence identity when 
compared with our nitroreductase from hypervirulent C. difficile strain R20291.  
Similar results were also obtained from 3D structural comparisons using the 
Dali server (http://ekhidna.biocenter.helsinki.fi/dali_server/start). 
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Fig. 4-4. Sequence alignment of C. difficile nitroreductases with potential homologs 
using CLUSTAL in JALVIEW (truncated display). Blue lines stand for the omitted gaps.  
 
The listed proteins in Fig. 4-4 are annotated as either nitroreductases or 
NAD(P)H:FMN oxidoreductases. The closest homolog of our C. difficile 
nitroreductase, based on sequence alignment, is the nitroreductase from B. 
fragilis (PDB_3EK3). The closest 3D structural homolog is the nitroreductase 
from D. hafniense (PDB_3PXV) as determined using a structural comparisons 
on the DALI server (RMSD 2.1, Z score 21). Most of the homologs from Fig. 4-4 
have a very similar overall protein fold (avg. RMSD 1.5-2.8 Å and Z score 21-15 
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from DALI server) as our C. difficile R20291 nitroreductase even with low 
sequence identities (an example is shown in Fig. 4-5).  
 
 
Fig. 4-5. Structural alignment of nitroreductases from hypervirulent C. difficile R20291 
(red) and from D. hafniense (3PXV, in blue) using PYMOL. Arrows represent the 
unique segment in each monomer of nitroreductase from C. difficile.  
 
The results from the structural comparisons showed that the segment 
described above in our nitroreductase (CDR20291_0684) is quite unique. No 
similar segment has been found so far for any of the other proteins. 
4.3.3 FMN co-factor binding sites 
The nitroreductase dimer contains two FMN cofactors located near the 
interface of the monomers (Fig. 4-6). The FMN in the left panel of Fig. 4-6 
interacts primarily with most residues from monomer A, and one residue (S45) 
from monomer B. Two water molecules underneath the FMN isoalloxazine 
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moiety of monomer A are involved in the interaction network of this FMN. There 
are no water molecules above the isoalloxazine group.  Unlike that observed for 
the first FMN, a phosphate group is present in the second FMN binding site 
(right panel in Fig. 4-6). More water molecules above the isoalloxazine group 
participate in FMN interactions, but there are no water molecules underneath 
the FMN in this case, probably due to an FMN positional shift after incorporation 
of a phosphate group. Similar to that seen for the first FMN, the second FMN 
also interacts mostly with residues from monomer B, but two extra residues 
(A43 and C47) other than S45 joined this network. C47 and two water 
molecules stabilize the phosphate group which occupies the proposed 
substrate binding position. Interestingly, C47 is located in a loop area that is 
above the FMN plane in both monomers, and this loop area is assumed to 
interact with substrates (see arrows in Fig. 4-6). C47 does not interact with the 
first FMN in monomer A but does interact with the phosphate group in the 
second FMN binding site, which provides additional support for the idea that 
C47 may function in the interaction with substrates. 
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Fig. 4-6. Two FMN binding sites around monomer A (left) and monomer B (right). 
Monomer A and monomer B are in yellow and cyan respectively. Water molecules 
involved in the FMN interaction networks are presented by red spheres. Arrows point to 
the loop that may interact with substrates. 
 
It is apparent that the FMN cofactor in monomer B is exposed to the 
solvent (Fig. 4-7 right), whereas the other FMN cofactor is blocked due to the 
interaction with a protein segment (residues 136-180) discussed above in the 
crystal, partially restricting its access to the solvent region (Fig. 4-7 left panel). 
 
4.3.4 Functional assays 
The nitroreductase was reduced anaerobically using dithionite, with a 
corresponding color change from yellow (oxidized FMN) to colorless (reduced 
FMN) (Fig. 4-8A). Oxidized nitroreductase has a typical absorption spectrum of 
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Fig. 4-7. View of the interaction between symmetry mates. The structure is shown 
in two different views with 90° rotation around the vertical axis. The upper regions of 
the two panels are the electrostatic surfaces of the nitroreductase with two FMN 
binding sites circled. A symmetry mate around nitroreductase was labeled green.  
 
a flavoprotein with absorbances at 370 nm and 450 nm. Upon dithionite 
addition, these absorbances decreased (Fig. 4-8A). Reduced nitroreductase is 
susceptible to react with oxygen, and even small amount of air leaking into the 
cuvette will cause changes in the spectra due to the re-oxidation of 
nitroreductase by oxygen.  
Reduced nitroreductase (in the absence of dithionite) can be 
anaerobically re-oxidized by the addition of nitro-containing metronidazole or 
nitrofurazone, with a corresponding color change from colorless (reduced FMN) 
back to yellow (oxidized FMN) (Fig. 4-8B, C). The absorbances at 450 nm 
increased as the reduced protein (lowest thick dashed line) became oxidized 
(top thick line). 
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Fig. 4-8. Reduction and re-oxidation of nitroreductase. A) Reduction of nitroreductase 
by sequential addition of dithionite; B) Re-oxidation of nitroreductase by sequential 
addition of nitrofurazone; C) Re-oxidation of nitroreductase by sequential addition of 
metronidazole. Conditions: 20 mM Tris buffer, pH 7, [protein] = 16-17 µM, each 
addition of [dithionite] = 7 µM, each addition of [substrates] = 0.3 µM. 
A 
B 
C 
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4.4 Discussion 
The overall structure of nitroreductase (CDR20291_0684) displays a 
conserved fold as observed with other nitroreductase structures (DALI server) 
even with low sequence similarity. A unique segment (136-180) on each 
monomer was observed in the structure of this C. difficile nitroreductase, 
however, the segment folded in a different way in each monomer in this 
homodimer structure. It is not clear what the physiological role is for this 
different folding of this segment in this nitroreductase. Instead of folding down in 
monomer B, the segment in monomer A inserts into another monomer A from a 
neighboring symmetry mate, and blocks the FMN binding site resulting in 
restricted solvent accessibility to FMN. This implies that the nitroreductase 
(CDR20291_0684) may interact with other proteins through this unique 
segment in hypervirulent C. difficile, and perhaps performs other roles other 
than simply work as a nitroreductase. To test this hypothesis, it would be 
interesting to design a further functional assay to find other interacting proteins, 
as this might help to determine the physiological role of this nitroreductase in 
vivo.  
RdxA, a type I nitroreductase (reduce nitro compounds by a 2e 
reduction) implicated in metronidazole resistance in H. pylori, was reported to 
have a cysteine (C159) close to the bound FMN co-factor (Fig. 4-9B), which 
presumably donates a proton to N1 of FMN and contributes to the reduction of 
metronidazole [40]. Another necessary protonation of N5 in FMN was proposed 
to be achieved by the light receptor photoropin protein in this single cysteine 
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system with only one cysteine beneath the isoalloxazine ring [40-42]. Our 
nitroreductase has a conserved cysteine (C130) underneath the isoalloxazine 
ring of FMN with an even closer distance of 3.5 Å than the 4.2 Å observed in 
RdxA, which implies that C130 in nitroreductase from hypervirulent C. difficile 
may perform a similar role to donate a proton to N1 of FMN as with the C159 in 
RdxA, but may be more active in the metabolism of metronidazole.  
 
 
Fig. 4-9. Cysteines around FMN binding site in this nitroreductase from hypervirulent 
C. difficile strain (A), RdxA (PDB ID 3QDL) from H. pylori (B) and peroxiredoxin 
nitroreductase fusion enzyme (PDB ID 4EO3) from T. maritima (C). Each monomer in 
the three structures is distinguished by a different color. FMN co-factors are in 
magenta. Red spheres represent water molecules. 
 
Perhaps most interesting, however, is the observation of another single 
cysteine (C47) above the isoalloxazine ring (Fig. 4-9A). This cysteine is located 
in a loop area which is proposed to interact with substrate. All three proteins in 
Fig. 9 have this loop. I checked 600 structural homologs (note: homologs here 
are actually extracted monomers from the published structures) of our 
nitroreductase using the DALI server, and none of the homologs had a cysteine 
in this position. We do find another structure with a cysteine in the neighboring 
position of C47 of this loop area in peroxiredoxin nitroreductase from T. 
A B
  A 
C
  A 
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maritima, but it formed a disulfide bond which was confirmed to have a role in 
structural need instead of catalytic function (Fig. 4-9C) [38]. In our structure, 
there is no other cysteine to form a disulfide bond; also there are no other 
residues which could donate a proton to the N5 of FMN from this position. 
Based on this information, we propose that C47 in the loop with a distance 6.6 
Å to N5 could donate a proton to N5 of FMN in nitroreductase with a relative 
positional adjustment of the loop, which provides another possible mechanism 
for the protonation of N5 for the unique two cysteine system on each side of the 
isoalloxazine ring.  
In conclusion, the first isolation and structural characterization of a C. 
difficile nitroreductase from the pathogenic strain was obtained. An initial 
functional assay shows that it indeed functions as a nitroreductase with 
metronidazole and nitrofurazone (also an antibiotic). 
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